FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1122,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,381460320.94968665,161498279.02847537,0.4233684872555237,-1.2400142062034838,0.2888508959797163,0.9897340531605416,Downregulated
Feature1121,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,5623479.9360757265,8392919.408563683,1.4924778791725493,0.5777095486796503,0.5758914656587489,0.9897340531605416,Upregulated
Feature1120,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,1419775.0307866267,1382906.84299831,0.974032373447299,-0.03795837161905692,0.9105372711837634,0.9897340531605416,Downregulated
Feature1119,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,1939945.0784148024,1504072.6984269693,0.7753171546773893,-0.3671415085233856,0.6489417848518149,0.9897340531605416,Downregulated
Feature1118,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,1175035.1991176321,1215685.14045247,1.0345946584113932,0.04906564807196741,0.9200284721307608,0.9897340531605416,Upregulated
Feature1117,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,881598040.494218,730462856.506479,0.8285667877584963,-0.2713101023477171,0.5522492462593187,0.9897340531605416,Downregulated
Feature1116,NA,C30 H32 O10,552.19968,NA,NA,Feature1116,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Phenol,2516132.0979702133,1656669.6076733032,0.6584191700466576,-0.6029217540721903,0.14733300977493863,0.9897340531605416,Downregulated
Feature1115,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,256669315.255487,220941478.37290114,0.8608020719304815,-0.21624654445537944,0.7627276929143276,0.9897340531605416,Downregulated
Feature1114,NA,C9 H16 O7,236.0896,NA,NA,Feature1114,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,363415983.2368768,291201169.07374907,0.8012888329238462,-0.31960572401828025,0.8327501906163347,0.9897340531605416,Downregulated
Feature1113,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,756203288.4034864,712408739.2198753,0.9420862751389628,-0.08606890870576742,0.7839413546799987,0.9897340531605416,Downregulated
Feature1112,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1117665234.5214992,716508611.4743503,0.6410762268910564,-0.6414321848150241,0.083311161554778565,0.9897340531605416,Downregulated
Feature1111,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,478260440.94052935,387318104.41750634,0.8098476713980793,-0.30427752563769295,0.585200135205878,0.9897340531605416,Downregulated
Feature1110,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,57971319.46533397,46707399.6574374,0.8056984054911458,-0.3116881945070555,0.3343545171442833,0.9897340531605416,Downregulated
Feature1109,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,651366702.833723,588185471.922101,0.9030020560818405,-0.14719882224690117,0.48912080861915835,0.9897340531605416,Downregulated
Feature1108,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,69989516.59390303,135733952.649896,1.9393469087300443,0.9555708945941507,0.5190850077272083,0.9897340531605416,Upregulated
Feature1107,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,6573246.25980719,5795783.24044752,0.8817231260429798,-0.18160239533349776,0.46548597660455726,0.9897340531605416,Downregulated
Feature1106,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,712591226.904913,659366331.017089,0.925307955138597,-0.11199450070603717,0.7710345640665572,0.9897340531605416,Downregulated
Feature1105,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,60173171.2393584,143149585.3746365,2.378960297857867,1.2503311950242841,0.442618672519665,0.9897340531605416,Upregulated
Feature1104,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,980039953.186361,908086481.0678383,0.9265810828583227,-0.11001086637445331,0.3912570737911994,0.9897340531605416,Downregulated
Feature1103,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,12938215.599931587,8877320.404750284,0.686131741752489,-0.5434424850706976,0.33561960938566804,0.9897340531605416,Downregulated
Feature1102,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,90458144.71914963,82824680.60609937,0.9156133022985349,-0.12718967194491979,0.4006221164702704,0.9897340531605416,Downregulated
Feature1101,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,880747483.1953499,547312116.2801284,0.6214177465423815,-0.6863646521352074,0.2725016476932024,0.9897340531605416,Downregulated
Feature1100,NA,C32 H36 O10,580.23111,NA,NA,Feature1100,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,1397367.9474576784,1190298.76028703,0.8518148440806999,-0.23138822377463011,0.499471685414346,0.9897340531605416,Downregulated
Feature1099,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,18974990.868771773,25456805.378431823,1.3415977670022252,0.4239521927496189,0.7239547807288895,0.9897340531605416,Upregulated
Feature1098,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,843639846.0867227,754692274.832554,0.8945668917053198,-0.16073873030344804,0.5719514919832598,0.9897340531605416,Downregulated
Feature1097,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,127938606.01852678,117337995.95033278,0.9171429922672526,-0.12478141215504654,0.9407709722739845,0.9897340531605416,Downregulated
Feature1096,NA,C6 H11 N O7,209.05352,NA,NA,Feature1096,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,235405092.358823,130571611.64008303,0.5546677445747669,-0.8503042635922238,0.20852580241536847,0.9897340531605416,Downregulated
Feature1095,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,432436992.58979267,581508583.450499,1.3447244186209455,0.42731054406427915,0.514795190559325,0.9897340531605416,Upregulated
Feature1094,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,6958915.329896926,6328856.392413166,0.9094601805576082,-0.13691762201299357,0.750198990252356,0.9897340531605416,Downregulated
Feature1093,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,139756922.975066,180466883.88785166,1.2912911936394642,0.36881437341670187,0.2419351435060894,0.9897340531605416,Upregulated
Feature1092,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,26276613.087375835,31198988.318278432,1.1873291361612914,0.24771991584471495,0.6990433679028872,0.9897340531605416,Upregulated
Feature1091,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,728320.615332342,626795.9789247733,0.860604472439323,-0.21657775710024949,0.5078586864403464,0.9897340531605416,Downregulated
Feature1090,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,2893434.3741580863,4040128.821157667,1.3963091256677418,0.4816183718467287,0.5893936110206662,0.9897340531605416,Upregulated
Feature1089,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3140093.7751261103,3936916.2725524465,1.2537575481784249,0.32625838652981953,0.44749291381427164,0.9897340531605416,Upregulated
Feature1088,NA,C16 H29 N O12,427.16894,NA,NA,Feature1088,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,5962213.38245727,7596417.459429231,1.274093524022523,0.34947118159050433,0.42888184342555785,0.9897340531605416,Upregulated
Feature1087,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,5857747.209973247,6514132.953474226,1.1120542966387206,0.15322723012891223,0.3973734678865881,0.9897340531605416,Upregulated
Feature1086,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,141905378.9538151,196707742.7264023,1.3861894748219752,0.4711244693821376,0.7549170958662053,0.9897340531605416,Upregulated
Feature1085,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,307302823.17543435,317631674.117899,1.0336113115907435,0.04769376373442648,0.8467514463745318,0.9897340531605416,Upregulated
Feature1084,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,1003119.7129663967,976159.7039521737,0.9731238369002861,-0.03930468503654014,0.9290188383571361,0.9897340531605416,Downregulated
Feature1083,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,259540309.60929933,295326531.8218637,1.137883099031651,0.18635234928745564,0.8207950626144983,0.9897340531605416,Upregulated
Feature1082,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,37701615.385787435,43715880.05927033,1.1595227316373855,0.21353110329488284,0.7829943152154188,0.9897340531605416,Upregulated
Feature1081,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,2709733.793858956,4629385.163832141,1.7084280287324431,0.7726694723631146,0.6842347723189364,0.9897340531605416,Upregulated
Feature1080,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,89174746.42393766,66618215.71214107,0.7470524827223772,-0.42071849457220256,0.4173455589155165,0.9897340531605416,Downregulated
Feature1079,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Phenol,280027721.6533033,288369515.23789835,1.029789170641194,0.042349003812394766,0.8629714069472892,0.9897340531605416,Upregulated
Feature1078,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,69440066.0982279,110316415.23499916,1.5886565412963283,0.6678072557578506,0.6109352736873932,0.9897340531605416,Upregulated
Feature1077,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,1379230.026514269,329148.48477593565,0.23864654803651086,-2.067052626574451,0.34507433741328597,0.9897340531605416,Downregulated
Feature1076,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,820634.0216315957,829850.5194958727,1.0112309478053965,0.016112521675671124,0.9265708582909682,0.9897340531605416,Upregulated
Feature1075,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,353133226.159715,259278081.42475733,0.7342217107248105,-0.445712319741753,0.3403635026677055,0.9897340531605416,Downregulated
Feature1074,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3094796.8362434767,2478972.5187660535,0.8010130066486295,-0.32010242594235583,0.3952129909753038,0.9897340531605416,Downregulated
Feature1073,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,243373482.58666167,241271941.425378,0.991364954230232,-0.012511835929756396,0.9601348147110581,0.9979064914529228,Downregulated
Feature1072,NA,C9 H17 N O6,235.10555,NA,NA,Feature1072,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,348099632.9854613,256983417.152727,0.7382467339845203,-0.43782502602018647,0.3374658637854363,0.9897340531605416,Downregulated
Feature1071,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1071,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,159783.31103547732,200367.5688051833,1.253995598831313,0.32653228469865886,0.5206533832213396,0.9897340531605416,Upregulated
Feature1070,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,163089668.549052,123185062.33718868,0.7553210662154155,-0.4048380700842178,0.27293998310072815,0.9897340531605416,Downregulated
Feature1069,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,8907881.799718827,13482643.28378223,1.5135633349117636,0.5979490458633738,0.5127124339781797,0.9897340531605416,Upregulated
Feature1068,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,84196.88395271944,308452.23742883117,3.663463811820421,1.873208364615503,0.41704441515446267,0.9897340531605416,Upregulated
Feature1067,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,362091.92751918634,326311.15741750965,0.9011831875214044,-0.15010769598972815,0.5785061160316917,0.9897340531605416,Downregulated
Feature1066,NA,C29 H30 O10,538.18407,NA,NA,Feature1066,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,617993.8381513903,534845.6044572307,0.8654545910313902,-0.20846996912841162,0.4475544302918935,0.9897340531605416,Downregulated
Feature1065,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,68931326.74707873,100198586.5387891,1.4536001447706859,0.5396304683692703,0.6690360911552571,0.9897340531605416,Upregulated
Feature1064,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,23066107.7241352,37272902.440391265,1.615916429688343,0.6923525881937881,0.5720871779682036,0.9897340531605416,Upregulated
Feature1063,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,155328205.19747433,129209812.01624607,0.8318502866364611,-0.2656041941202447,0.45607526493347134,0.9897340531605416,Downregulated
Feature1062,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,51263220.708418965,26310899.476177566,0.5132510035963567,-0.9622635515460398,0.007041571791230957,0.9897340531605416,Downregulated
Feature1061,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,4328889.699525436,3143525.61139958,0.7261736448827041,-0.4616135237233437,0.6290193578883532,0.9897340531605416,Downregulated
Feature1060,NA,C9 H19 N O7,253.11617,NA,NA,Feature1060,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,53888767.933246806,47853946.850989945,0.8880133780432256,-0.1713466837497787,0.9161151805187873,0.9897340531605416,Downregulated
Feature1059,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,82792232.73025207,56318385.8874497,0.6802375540582698,-0.5558894393884103,0.5928447509278909,0.9897340531605416,Downregulated
Feature1058,NA,C6 H14 O4,150.08923,NA,NA,Feature1058,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,307938170.2185107,302675852.00381136,0.982911120726069,-0.024867127441482978,0.9288465817006115,0.9897340531605416,Downregulated
Feature1057,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1057,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,175590.7577705,152388.74004136102,0.8678631038231271,-0.204460604074048,0.5458436401468887,0.9897340531605416,Downregulated
Feature1056,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1056,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,38095682.3000742,33054140.093131002,0.8676610601896642,-0.20479651106445615,0.26822066867285005,0.9897340531605416,Downregulated
Feature1055,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Phenol,178958060.261837,176966945.94427332,0.9888738494670178,-0.016141606619354675,0.9121935371373606,0.9897340531605416,Downregulated
Feature1054,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,1483321.0505763076,1066037.239932164,0.7186827420253907,-0.4765730523418679,0.5078460764744006,0.9897340531605416,Downregulated
Feature1053,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,55901983.86684847,63243345.9218338,1.131325608630841,0.17801421345698204,0.44166065424547324,0.9897340531605416,Upregulated
Feature1052,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1546943.6871439593,1545222.805111428,0.9988875600018069,-0.0016058050152377061,0.9981667881124225,0.9990212121416295,Downregulated
Feature1051,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,7073970.065893884,7244763.913736243,1.0241439879235306,0.03441856305251946,0.967408958827528,0.9990212121416295,Upregulated
Feature1050,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Phenol,493421.142350191,562698.9783539224,1.140403055438114,0.18954380975110371,0.5474478070170554,0.9897340531605416,Upregulated
Feature1049,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,24985989.245242734,36442244.934220284,1.4585071888301877,0.5444924971473707,0.6141591994500694,0.9897340531605416,Upregulated
Feature1048,NA,C6 H15 N O7,213.0849,NA,NA,Feature1048,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,6811622.304104997,5089082.5436814735,0.7471175465225895,-0.42059284993989193,0.26122632445939326,0.9897340531605416,Downregulated
Feature1047,NA,C10 H20 O7,252.12091,NA,NA,Feature1047,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,1996714.462050357,4165245.0100614703,2.0860494022687273,1.0607733244752005,0.43424985392870646,0.9897340531605416,Upregulated
Feature1046,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,162647464.235339,108524312.80717497,0.6672364264477448,-0.5837300428838632,0.37181055718266814,0.9897340531605416,Downregulated
Feature1045,NA,C12 H18 O9,306.09515,NA,NA,Feature1045,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,4180694.20336399,3499962.4503688766,0.8371725555896044,-0.2564030773259427,0.6236390390183281,0.9897340531605416,Downregulated
Feature1044,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,359651.0243001353,343747.72335268866,0.9557812994460567,-0.0652475544010875,0.9168545343988954,0.9897340531605416,Downregulated
Feature1043,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,257014807.125892,204405891.578029,0.7953078418470501,-0.33041469871512147,0.35653181075661866,0.9897340531605416,Downregulated
Feature1042,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Phenol,575398.1765689506,490132.7080574767,0.8518148440790957,-0.23138822377734702,0.4994716854072686,0.9897340531605416,Downregulated
Feature1041,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,7301116.903780793,8535299.22178811,1.1690402077205764,0.22532455046967287,0.7711734055457676,0.9897340531605416,Upregulated
Feature1040,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,39938125.75096373,16958034.484403323,0.42460766912663933,-1.2357976659166794,0.4104277671489865,0.9897340531605416,Downregulated
Feature1039,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Phenol,610906.8182584806,438402.348775162,0.7176255619881946,-0.4786968145844919,0.11502510516282811,0.9897340531605416,Downregulated
Feature1038,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1269250.67880766,1204578.558625352,0.9490470076068337,-0.07544854719663134,0.876572031472489,0.9897340531605416,Downregulated
Feature1037,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,322061.58169343235,357647.244703904,1.1104933498225982,0.15120075334713057,0.8174685910980152,0.9897340531605416,Upregulated
Feature1036,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,14256018.034291632,16754250.365452664,1.1752405422854928,0.2329560705314624,0.7467818152786767,0.9897340531605416,Upregulated
Feature1035,NA,C9 H17 N O6,235.10557,NA,NA,Feature1035,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,79084460.141933,94668465.9166707,1.197055221048093,0.2594897064122888,0.7690211858962276,0.9897340531605416,Upregulated
Feature1034,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,111725.0230608379,104535.25860779973,0.9356476798476638,-0.09596271275338343,0.7554768357213915,0.9897340531605416,Downregulated
Feature1033,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1033,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,11810585.03366318,12677243.90557583,1.0733798426955525,0.10216070069872117,0.789698375495349,0.9897340531605416,Upregulated
Feature1032,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,5785880.34477042,7582298.399661831,1.3104830981365017,0.3900987467285989,0.7376812121165319,0.9897340531605416,Upregulated
Feature1031,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,8674945.55253313,5720111.34635204,0.6593829680788875,-0.6008114723398899,0.3904270516090582,0.9897340531605416,Downregulated
Feature1030,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,206395835.149803,173477875.943535,0.840510545271536,-0.2506621748720679,0.44786152845215926,0.9897340531605416,Downregulated
Feature1029,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Phenol,538708.451115591,401943.12170741835,0.7461236609060977,-0.422513335464575,0.3773164835935218,0.9897340531605416,Downregulated
Feature1028,NA,C22 H33 N O6,407.23081,NA,NA,Feature1028,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,632766.3460062731,488548.0116439507,0.7720827991681899,-0.3731725225961964,0.33503283012691476,0.9897340531605416,Downregulated
Feature1027,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,241040.90774990467,254526.08277573134,1.0559455867956589,0.07853549408781094,0.7447502691592411,0.9897340531605416,Upregulated
Feature1026,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Phenol,12445950.6629486,22338246.529090926,1.7948204306796376,0.8438395116098656,0.5743835450937745,0.9897340531605416,Upregulated
Feature1025,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,13432289.404316343,13418283.827379933,0.9989573201920507,-0.0015050537691775909,0.9960254922904987,0.9990212121416295,Downregulated
Feature1024,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,183384852.38509235,111417013.06127666,0.6075584303294067,-0.7189049321066973,0.2541920125380071,0.9897340531605416,Downregulated
Feature1023,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,26097756.4342352,19202855.55692746,0.7358048422789721,-0.4426049242724892,0.6101544740329283,0.9897340531605416,Downregulated
Feature1022,NA,C10 H15 N O8,277.07983,NA,NA,Feature1022,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,45983422.78136027,58475716.82058943,1.2716695122637327,0.34672378464075887,0.7014977976865777,0.9897340531605416,Upregulated
Feature1021,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1021,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,153315638.098722,144414766.10566598,0.9419441349660324,-0.08628659619306812,0.7460635561551497,0.9897340531605416,Downregulated
Feature1020,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,7462099.14753481,6343724.382561794,0.8501259842758208,-0.23425143784693406,0.4683839097707393,0.9897340531605416,Downregulated
Feature1019,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1019,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,660624.0470667733,579469.5472983033,0.8771547900370826,-0.1890966397729721,0.48914419025511224,0.9897340531605416,Downregulated
Feature1018,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,9278428.30361528,23320243.109599654,2.513382907804878,1.329630479061471,0.5147117995587062,0.9897340531605416,Upregulated
Feature1017,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,58918386.6886832,53879422.65307387,0.9144755259129118,-0.12898353521030922,0.8472313704058372,0.9897340531605416,Downregulated
Feature1016,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,28854259.753161833,26399140.74357973,0.9149131174882048,-0.1282933470319494,0.8183903940371635,0.9897340531605416,Downregulated
Feature1015,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,317612.33609786164,277642.50974523165,0.8741553088154781,-0.19403847265306715,0.4668943770995915,0.9897340531605416,Downregulated
Feature1014,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,129550385.2790322,63830145.44974714,0.49270517654012785,-1.0212034656778184,0.3011508950358586,0.9897340531605416,Downregulated
Feature1013,NA,C10 H17 N O9,295.09039,NA,NA,Feature1013,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,53635101.8124524,76733714.93917933,1.4306622407000662,0.5166831121883234,0.546386499125455,0.9897340531605416,Upregulated
Feature1012,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,41301714.10165947,36671711.0748481,0.8878980418242414,-0.17153407484320354,0.7028866003128051,0.9897340531605416,Downregulated
Feature1011,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,12466804.824313743,10714400.43235376,0.8594343605554563,-0.21854063705408336,0.8671666503374437,0.9897340531605416,Downregulated
Feature1010,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,70795182.12669523,69538849.4324788,0.9822539803348751,-0.025831986036181673,0.9748508487383369,0.9990212121416295,Downregulated
Feature1009,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,158938650.248421,157057749.20303068,0.9881658675064215,-0.01717487074498921,0.8976051835148297,0.9897340531605416,Downregulated
Feature1008,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,21039988.167529367,29904193.770096265,1.4213027845826864,0.5072139291643732,0.298835307481677,0.9897340531605416,Upregulated
Feature1007,NA,C7 H15 N O5,193.09509,NA,NA,Feature1007,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,49457536.88322437,42696846.98698157,0.8633031420022865,-0.21206085568021868,0.5578397889156732,0.9897340531605416,Downregulated
Feature1006,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,22340492.577219065,25804745.845769934,1.155066109512886,0.2079754257858818,0.627749202632136,0.9897340531605416,Upregulated
Feature1005,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,12766958.602546323,13934957.378212674,1.0914860627364609,0.1262937085702375,0.7432374907740419,0.9897340531605416,Upregulated
Feature1004,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,62158683.005098894,30862888.144440264,0.496517729339738,-1.0100828613757056,0.22568180109351765,0.9897340531605416,Downregulated
Feature1003,NA,C6 H14 O4,150.08924,NA,NA,Feature1003,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,165880692.44635135,138632594.80592734,0.8357367741924726,-0.25887947598445127,0.37265173082874864,0.9897340531605416,Downregulated
Feature1002,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,1430342.437145562,1420690.73607505,0.9932521745703266,-0.009768048015325305,0.9776126613269275,0.9990212121416295,Downregulated
Feature1001,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,225619.32448482135,233359.348913134,1.0343056803577717,0.04866262507488603,0.8122430787422092,0.9897340531605416,Upregulated
Feature1000,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,45879230.394297704,39916052.630740404,0.8700244596016925,-0.20087213386849664,0.785979998458129,0.9897340531605416,Downregulated
Feature0999,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,3928017.7613749234,3671319.024125813,0.9346492931439143,-0.09750296834273874,0.7917520480655184,0.9897340531605416,Downregulated
Feature0998,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,23319256.566259168,26824940.294100534,1.150334283508582,0.20205316471777773,0.5765764016949952,0.9897340531605416,Upregulated
Feature0997,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,42566295.606997564,39854728.95422557,0.9362978005460678,-0.09496062593504431,0.8401841837124674,0.9897340531605416,Downregulated
Feature0996,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,85091807.6904823,84331949.91453123,0.991070141808304,-0.01294092883987816,0.9743023411599279,0.9990212121416295,Downregulated
Feature0995,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,100094845.5449857,91535733.58533096,0.9144899828452404,-0.12896072784245294,0.7217973087522102,0.9897340531605416,Downregulated
Feature0994,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,7822195.08283682,5137475.549012713,0.6567818233382057,-0.6065138942982855,0.10806944410473587,0.9897340531605416,Downregulated
Feature0993,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,5218164.494113463,4094371.332635537,0.784638226191286,-0.34990047220087295,0.19391748081137805,0.9897340531605416,Downregulated
Feature0992,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,1098741.6929248758,664200.8430816203,0.6045104571516735,-0.7261607986712375,0.36945118368800206,0.9897340531605416,Downregulated
Feature0991,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,65577507.2901124,36093367.7868636,0.5503924939871214,-0.8614672995591905,0.484144495391409,0.9897340531605416,Downregulated
Feature0990,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,35619428.4426376,28459886.228727233,0.7989989585194982,-0.3237344722594349,0.49017495915015125,0.9897340531605416,Downregulated
Feature0989,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,56623128.693428405,65138719.37022327,1.1503906773308197,0.20212388945809245,0.7569847122752026,0.9897340531605416,Upregulated
Feature0988,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,689108.3984053027,767970.3647547923,1.1144405822538046,0.15631969961882825,0.6564160377351285,0.9897340531605416,Upregulated
Feature0987,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,5860682.968333676,11952182.496579695,2.0393839013574846,1.0281333793033605,0.4667063526061449,0.9897340531605416,Upregulated
Feature0986,NA,C18 H31 N O11,437.18971,NA,NA,Feature0986,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,9865182.81111112,6909714.310681607,0.7004142186700504,-0.5137197235708382,0.35335341453306796,0.9897340531605416,Downregulated
Feature0985,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Phenol,56115267.68724293,63818569.1210777,1.1372763911021315,0.18558291352198142,0.10693329864606359,0.9897340531605416,Upregulated
Feature0984,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,290491.1092005273,256347.4897034317,0.8824624285711749,-0.18039323890345035,0.7557784007529387,0.9897340531605416,Downregulated
Feature0983,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,9605813.224214258,8910889.56873024,0.9276559267535768,-0.1083382947203895,0.5039644396313321,0.9897340531605416,Downregulated
Feature0982,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,110711949.39363533,77491513.00667217,0.699938113555853,-0.5147007259912341,0.15856619964872395,0.9897340531605416,Downregulated
Feature0981,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,31233925.53620833,38313897.11186462,1.226675688505716,0.294753876198028,0.7155839799694697,0.9897340531605416,Upregulated
Feature0980,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,16325294.0809205,13694790.88796975,0.8388694758016617,-0.253481743415013,0.6114656841832828,0.9897340531605416,Downregulated
Feature0979,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,1036789.503841758,1194306.2732910323,1.1519274345135688,0.2040498372968872,0.8200993625301404,0.9897340531605416,Upregulated
Feature0978,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,30153958.9137516,27519963.6105517,0.9126484415948887,-0.13186886363944436,0.6049022134054303,0.9897340531605416,Downregulated
Feature0977,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,5424589.8226044495,4595619.560452037,0.847182867412746,-0.23925468089775784,0.452227365212427,0.9897340531605416,Downregulated
Feature0976,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,12215103.882184267,14028920.3310566,1.1484896457997205,0.1997378501675286,0.5905710147513024,0.9897340531605416,Upregulated
Feature0975,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,1417238.70691793,1281125.9819075665,0.9039592100145445,-0.14567042051838536,0.2823798829813967,0.9897340531605416,Downregulated
Feature0974,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,39050477.95431773,40220705.0561848,1.0299670365939189,0.042598165657544936,0.8964418504583715,0.9897340531605416,Upregulated
Feature0973,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,103888310.2845349,66106294.81904954,0.6363208202924281,-0.6521737678266983,0.2812333312245496,0.9897340531605416,Downregulated
Feature0972,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature0972,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,863840.0456787583,779174.569408917,0.9019894056852669,-0.14881760647886574,0.8043419074058002,0.9897340531605416,Downregulated
Feature0971,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,15890127.12292874,17681303.727263816,1.112722610113703,0.15409398900454757,0.9080460819624127,0.9897340531605416,Upregulated
Feature0970,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,2606095.80467475,3414479.3580932734,1.3101894995450531,0.38977549136732903,0.46307766987530774,0.9897340531605416,Upregulated
Feature0969,NA,C43 H79 N O9,753.57577,NA,NA,Feature0969,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,35539041.43560482,11459601.70418051,0.3224510634296315,-1.6328478673884945,0.5376025325464283,0.9897340531605416,Downregulated
Feature0968,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature0968,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,142699.49724191232,147864.01654572366,1.0361915732264715,0.051290756106716455,0.8525958295590599,0.9897340531605416,Upregulated
Feature0967,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature0967,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,185168.66473197268,367814.24534430733,1.986374130184013,0.9901373776129594,0.3018408384689641,0.9897340531605416,Upregulated
Feature0966,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,62419544.90779947,42356670.707142,0.6785802551061124,-0.5594086428445473,0.37029192225674534,0.9897340531605416,Downregulated
Feature0965,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,67113430.15247643,82595654.4358158,1.2306874234883387,0.2994643850180751,0.4889841541743888,0.9897340531605416,Upregulated
Feature0964,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,627397.239165007,511142.20899793564,0.8147026749403722,-0.2956544498404537,0.3803245611987021,0.9897340531605416,Downregulated
Feature0963,NA,C12 H18 N6,246.15928,NA,NA,Feature0963,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,33963960.54111997,500504.71725515067,0.014736347271667345,-6.08447722477946,0.4198398565013374,0.9897340531605416,Downregulated
Feature0962,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,3180281.27090867,2770368.7442239802,0.871108090207515,-0.19907635019516384,0.489058875951701,0.9897340531605416,Downregulated
Feature0961,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,101347754.4887007,99060149.12421267,0.9774281593506536,-0.03293742618334009,0.7905720045775144,0.9897340531605416,Downregulated
Feature0960,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,85853593.82450937,79448469.38301459,0.9253948011240241,-0.11185910103457211,0.6401593328345232,0.9897340531605416,Downregulated
Feature0959,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,287178.29392893,264003.6379774574,0.9193022020069253,-0.121388898587195,0.7064577176212403,0.9897340531605416,Downregulated
Feature0958,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,92550578.20807888,51262362.14458974,0.5538848393722403,-0.8523420444919586,0.06688141590811254,0.9897340531605416,Downregulated
Feature0957,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Phenol,22238106.219805416,31575104.609143402,1.4198648165922685,0.50575357922584,0.7282092316364657,0.9897340531605416,Upregulated
Feature0956,NA,C9 H15 N O7,249.08484,NA,NA,Feature0956,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,53455161.4903797,49697914.6182384,0.9297121780687635,-0.10514394161451525,0.4155484042611046,0.9897340531605416,Downregulated
Feature0955,NA,C23 H35 N O6,421.24649,NA,NA,Feature0955,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,2573940.3878546366,2501548.84624858,0.9718752066102065,-0.041157018055292344,0.8924872962587667,0.9897340531605416,Downregulated
Feature0954,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature0954,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,36788985.0480717,29108705.886573967,0.791234274295363,-0.3378231734857802,0.3803300023661489,0.9897340531605416,Downregulated
Feature0953,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,79257037.65683393,80158567.57086663,1.0113747616702018,0.01631768232457404,0.9254867892061094,0.9897340531605416,Upregulated
Feature0952,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,11678227.963399107,18224230.140417267,1.5605304330018281,0.6420364925424149,0.4749923799842359,0.9897340531605416,Upregulated
Feature0951,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1502991.1017723246,4059631.278047017,2.7010348053690447,1.4335122304465806,0.46042357376891724,0.9897340531605416,Upregulated
Feature0950,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,44443690.59052697,13984887.005861519,0.3146652948943523,-1.6681100253861127,0.17705770393106862,0.9897340531605416,Downregulated
Feature0949,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature0949,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,3525014.9014267568,3681583.3792388104,1.0444164016863253,0.06269701926063671,0.7539758014130953,0.9897340531605416,Upregulated
Feature0948,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,12146036.9632766,11268658.995436933,0.927764260022227,-0.10816982412732759,0.45626137510370457,0.9897340531605416,Downregulated
Feature0947,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,55942293.3742723,50334217.974550165,0.8997524938385656,-0.1523998990226662,0.6065866340751814,0.9897340531605416,Downregulated
Feature0946,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,34329693.02327937,18163868.4237941,0.5291008111105732,-0.9183854654915629,0.3448573038230536,0.9897340531605416,Downregulated
Feature0945,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature0945,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Phenol,386540.24978773866,336787.0466525137,0.8712858410927554,-0.1987819961837857,0.6834622569812833,0.9897340531605416,Downregulated
Feature0944,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1487224.0856103434,828556.39614678,0.5571160420030099,-0.843950236288355,0.18046923707610277,0.9897340531605416,Downregulated
Feature0943,NA,C15 H18 O11,374.08496,NA,NA,Feature0943,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,116192.25048866487,103183.8451067484,0.8880441223299526,-0.17129673645923002,0.5399673612186213,0.9897340531605416,Downregulated
Feature0942,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,19080492.286561865,14970669.569990467,0.7846060439716279,-0.34995964607149943,0.12483610637479209,0.9897340531605416,Downregulated
Feature0941,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,17213242.357991133,6434924.614264887,0.3738357062797943,-1.4195237226672974,0.3591556807011641,0.9897340531605416,Downregulated
Feature0940,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,71923176.0162513,67336821.851364,0.9362325967939599,-0.09506109867501705,0.6542031539397134,0.9897340531605416,Downregulated
Feature0939,NA,C10 H21 N O9,299.12162,NA,NA,Feature0939,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,21533055.23863473,25272041.038415533,1.1736393539302445,0.23098915271571294,0.5807340774541324,0.9897340531605416,Upregulated
Feature0938,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature0938,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,1140123.2071133696,922032.822440683,0.8087133186027671,-0.30629972366478864,0.6911554993971384,0.9897340531605416,Downregulated
Feature0937,NA,C16 H27 N O14,457.14329,NA,NA,Feature0937,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,76090230.64353333,63086924.96353936,0.8291067648235723,-0.2703702040663949,0.6451533149425397,0.9897340531605416,Downregulated
Feature0936,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,47445844.93507697,29804217.578534517,0.6281733968341683,-0.6707652487903668,0.2673738396990569,0.9897340531605416,Downregulated
Feature0935,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,4916287.628218616,8471365.2877639,1.7231223899797419,0.785025176981271,0.29001449959688896,0.9897340531605416,Upregulated
Feature0934,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,36058411.201271564,29504667.3558184,0.8182464610303725,-0.2893926373545343,0.45800171980875537,0.9897340531605416,Downregulated
Feature0933,NA,C23 H41 N,331.32396,NA,NA,Feature0933,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,60160278.48004016,50470366.80598792,0.8389317350439602,-0.2533746734003126,0.8312611916103293,0.9897340531605416,Downregulated
Feature0932,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,6843183.45864353,10571574.740098236,1.5448328696705373,0.627450766194433,0.10042314870257144,0.9897340531605416,Upregulated
Feature0931,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,74172493.91200203,65793555.58193134,0.8870344262657336,-0.17293799753233724,0.4075831201929361,0.9897340531605416,Downregulated
Feature0930,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,252266.43535047094,222128.6335088304,0.8805318598973723,-0.1835528894857538,0.8516962126373666,0.9897340531605416,Downregulated
Feature0929,NA,C9 H15 N O7,249.08488,NA,NA,Feature0929,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,9158653.646232544,12379596.536298793,1.351683010896607,0.4347568585526531,0.2352876221726726,0.9897340531605416,Upregulated
Feature0928,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,82950892.66528401,70663208.00509334,0.8518679634977186,-0.23129825970480222,0.5433794581993472,0.9897340531605416,Downregulated
Feature0927,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,1743215.0191785733,1475568.51153457,0.8464638586178991,-0.24047962405627568,0.3497892875843727,0.9897340531605416,Downregulated
Feature0926,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,75519122.02441509,74163291.26913677,0.9820465238613343,-0.02613672192160356,0.9189940212173244,0.9897340531605416,Downregulated
Feature0925,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature0925,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Phenol,3148973.4504759,3542235.3200928764,1.1248857368287888,0.16977846341337519,0.8134087866543702,0.9897340531605416,Upregulated
Feature0924,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Phenol,9835754.54118603,7240428.513087753,0.736133509917245,-0.44196064840453614,0.05860575339532841,0.9897340531605416,Downregulated
Feature0923,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,450238.66141598095,291989.922382878,0.6485225446090801,-0.624771367086751,0.16076698320318186,0.9897340531605416,Downregulated
Feature0922,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,58435162.7961925,73145461.14392887,1.2517370987575116,0.32393158611511647,0.5566130146785468,0.9897340531605416,Upregulated
Feature0921,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,7952395.619784759,8151917.788064176,1.0250895676999552,0.035749971419602934,0.9277946576753784,0.9897340531605416,Upregulated
Feature0920,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1640573.58522466,848864.6658595,0.517419440069344,-0.9505938360622965,0.17280892933051484,0.9897340531605416,Downregulated
Feature0919,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,250392.61683092936,286464.70340682135,1.1440621014806067,0.19416536598555198,0.8003366484569331,0.9897340531605416,Upregulated
Feature0918,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,66276810.263200566,54479697.06621193,0.8220023994797039,-0.2827854896514297,0.576642522486001,0.9897340531605416,Downregulated
Feature0917,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Phenol,1349396.78645837,1082713.6459060656,0.8023686263161767,-0.3176628991353868,0.2609212590073916,0.9897340531605416,Downregulated
Feature0916,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,817988.4492995983,722022.8330824478,0.8826809641391379,-0.18003600992922536,0.40793203330800953,0.9897340531605416,Downregulated
Feature0915,NA,C5 H13 O6 P,200.04503,NA,NA,Feature0915,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,23636782.608974252,10600811.865515413,0.4484879368265023,-1.1568589140118,0.4638330067209808,0.9897340531605416,Downregulated
Feature0914,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,14903004.521891333,15436519.492639868,1.0357991551277357,0.05074428681607449,0.8207146474954,0.9897340531605416,Upregulated
Feature0913,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Phenol,1298301.1433129627,2320352.752380577,1.7872222976401115,0.8377190903150993,0.13423898216062638,0.9897340531605416,Upregulated
Feature0912,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,11417939.330439894,10160351.337190744,0.8898585850866753,-0.16835201139760578,0.7631880958702507,0.9897340531605416,Downregulated
Feature0911,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,250804.85905767567,189323.96417252166,0.7548656149799087,-0.4057082635072371,0.5054683760888984,0.9897340531605416,Downregulated
Feature0910,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,15048562.600316932,18091735.98266817,1.202223525473931,0.2657051565417398,0.28480601231630603,0.9897340531605416,Upregulated
Feature0909,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,72038442.40857577,63458012.9244986,0.8808909632524797,-0.18296464158757864,0.3172113318538316,0.9897340531605416,Downregulated
Feature0908,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,8714266.46433791,7431623.820162736,0.8528111747071042,-0.22970175248809502,0.7003331816034648,0.9897340531605416,Downregulated
Feature0907,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,15883201.2780117,18175454.957911532,1.1443193749029152,0.19448975865863674,0.434896932832461,0.9897340531605416,Upregulated
Feature0906,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,34695401.33494057,56397011.694547765,1.6254895324629735,0.7008742656484581,0.3862159507289661,0.9897340531605416,Upregulated
Feature0905,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,179635.444263619,155757.07678010967,0.8670731849085012,-0.2057743262977216,0.4231845180226872,0.9897340531605416,Downregulated
Feature0904,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,60758845.36970357,37687950.059531555,0.6202874631703263,-0.6889911284571032,0.26927432441531624,0.9897340531605416,Downregulated
Feature0903,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature0903,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,57573092.99556733,55097658.67330757,0.9570036245499204,-0.06340370611096931,0.7417851595452563,0.9897340531605416,Downregulated
Feature0902,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Phenol,780034.5135752549,750703.4842628227,0.9623977800956591,-0.05529478014631295,0.7750150826680534,0.9897340531605416,Downregulated
Feature0901,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,15589444.4676257,17100249.154709235,1.0969120285344993,0.13344782739455877,0.6526188228832933,0.9897340531605416,Upregulated
Feature0900,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,574701.1288006577,4306647.016564691,7.4937159520675065,2.9056812936117717,0.36943521927020695,0.9897340531605416,Upregulated
Feature0899,NA,C12 H18 O9,306.09516,NA,NA,Feature0899,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,4939370.635321846,6074851.537856303,1.2298837213013616,0.29852192318095744,0.20385925537586003,0.9897340531605416,Upregulated
Feature0898,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,453455.3417109457,491487.36652863736,1.083871599514501,0.11619385843015749,0.7901097446360502,0.9897340531605416,Upregulated
Feature0897,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,10005859.326148566,10505849.296235394,1.0499697181210805,0.07034772013279841,0.8026744926851905,0.9897340531605416,Upregulated
Feature0896,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Phenol,13954298.202230666,9583202.862866692,0.6867563473263577,-0.5421297554559925,0.3088770404943246,0.9897340531605416,Downregulated
Feature0895,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,50221076.55492513,33471619.1542322,0.666485496734133,-0.5853546134476835,0.42532647129275897,0.9897340531605416,Downregulated
Feature0894,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,55720830.29160963,48436071.0497675,0.8692632682657807,-0.20213491174935477,0.27502000425954215,0.9897340531605416,Downregulated
Feature0893,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,11902783.047762163,4393807.5620506,0.36914119533386586,-1.4377553467714745,0.3509353288466046,0.9897340531605416,Downregulated
Feature0892,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,620741.4993685813,673186.0837376664,1.084486995669585,0.11701275342928821,0.6236681755616678,0.9897340531605416,Upregulated
Feature0891,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,44689252.54036337,43304009.05716057,0.9690027600718618,-0.045427319921601914,0.929181902094277,0.9897340531605416,Downregulated
Feature0890,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,11935382.3309547,14079855.0959018,1.1796735710246464,0.23838770482882118,0.043726552358975754,0.9897340531605416,Upregulated
Feature0889,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,9170047.621902866,17012230.85076893,1.8551954746815962,0.8915712059814279,0.40593340640311687,0.9897340531605416,Upregulated
Feature0888,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,51144548.8701103,42270707.31897697,0.826494870965235,-0.27492222837156416,0.22488079545634299,0.9897340531605416,Downregulated
Feature0887,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Phenol,1477592.3556667145,1234443.808140572,0.8354427412989492,-0.2593871411368653,0.5118506692854332,0.9897340531605416,Downregulated
Feature0886,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,7169381.414333084,9321348.853554588,1.300160824882224,0.37869009010709653,0.3579822269550915,0.9897340531605416,Upregulated
Feature0885,NA,C6 H15 N O6,197.08997,NA,NA,Feature0885,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,21427814.778204698,18901936.497278433,0.8821215178929276,-0.18095068492578112,0.6380384770542868,0.9897340531605416,Downregulated
Feature0884,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,19592555.787089366,17653935.927039634,0.9010532428174992,-0.1503157381501048,0.653896372705634,0.9897340531605416,Downregulated
Feature0883,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,57847806.0815107,52862812.9761568,0.9138257188469728,-0.13000904834576837,0.6173574968957027,0.9897340531605416,Downregulated
Feature0882,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,31549969.719391633,24027940.756985333,0.7615836392456815,-0.3929256086688314,0.12737277691555482,0.9897340531605416,Downregulated
Feature0881,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,12472035.691924367,12809430.168417268,1.0270520775298424,0.03850933656282475,0.8594705702958317,0.9897340531605416,Upregulated
Feature0880,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,8909701.791401394,2556351.782441373,0.2869177714689021,-1.8012907645778788,0.196023176288342,0.9897340531605416,Downregulated
Feature0879,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Phenol,131402.07390875893,118931.4550172713,0.9050957224606151,-0.14385771593309962,0.5845252952128085,0.9897340531605416,Downregulated
Feature0878,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature0878,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,1882847.4831910732,3400961.4074521097,1.806286190365307,0.8530264934333868,0.31049205224224197,0.9897340531605416,Upregulated
Feature0877,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Phenol,695281.828640052,719257.200375647,1.0344829546063214,0.04890987380350295,0.8588147063968498,0.9897340531605416,Upregulated
Feature0876,NA,C30 H46 O11,582.30426,NA,NA,Feature0876,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,634040.875443785,516554.79727703,0.8147026749899637,-0.2956544497526358,0.38032456134706344,0.9897340531605416,Downregulated
Feature0875,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,23674173.939590998,26196933.910689034,1.1065616894399493,0.1460838818377503,0.549899902087644,0.9897340531605416,Upregulated
Feature0874,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature0874,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Phenol,36532207.64331743,36537084.80352806,1.0001335030244614,1.9259129585986415e-4,0.9990212121416295,0.9990212121416295,Upregulated
Feature0873,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,36083691.602779865,29772433.233682744,0.8250938834481418,-0.27736980888777346,0.6606970400461987,0.9897340531605416,Downregulated
Feature0872,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,37007930.6624135,36279290.42839017,0.9803112408345662,-0.0286882290064357,0.9099385193211115,0.9897340531605416,Downregulated
Feature0871,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,110268.21933028306,87567.06107860587,0.794127824049819,-0.3325568503901202,0.49938685787109116,0.9897340531605416,Downregulated
Feature0870,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,2204730.0791906733,2191653.26007635,0.99406874372616,-0.00858247166767526,0.9802979331394117,0.9990212121416295,Downregulated
Feature0869,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,118537.3009208262,162256.44969437798,1.3688218681708706,0.4529347134858832,0.5045660325294252,0.9897340531605416,Upregulated
Feature0868,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,31973281.992252834,9557042.839475563,0.29890715760087583,-1.7422306508266854,0.2892972615302945,0.9897340531605416,Downregulated
Feature0867,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,236635.07863217534,241112.49941851333,1.0189212048028504,0.027042489349152498,0.9303770397467646,0.9897340531605416,Upregulated
Feature0866,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,16054184.503362333,16714718.513047954,1.041144040019428,0.05816967617461452,0.9079246243385483,0.9897340531605416,Upregulated
Feature0865,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,13957374.633444099,13676773.794500394,0.979895872518078,-0.029299643805644524,0.960312422757049,0.9979064914529228,Downregulated
Feature0864,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,11951044.234889913,11866701.628236454,0.9929426579806951,-0.01021768975764641,0.9865432613558381,0.9990212121416295,Downregulated
Feature0863,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,395451.65654113237,387770.3436817967,0.9805758485714252,-0.028298866177615078,0.9861786036201037,0.9990212121416295,Downregulated
Feature0862,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Phenol,25481322.165086,25499402.27435373,1.0007095436080826,0.00102329205242408,0.9986387189406674,0.9990212121416295,Upregulated
Feature0861,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature0861,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,719874.5114559947,561128.1425361893,0.779480497790191,-0.35941516701670245,0.2589158580365368,0.9897340531605416,Downregulated
Feature0860,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,372666.6195937167,126983.29645025267,0.340742341207513,-1.5532468646393152,0.12355197478091577,0.9897340531605416,Downregulated
Feature0859,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature0859,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,190364.38120247368,166045.32426879066,0.8722499619935885,-0.19718646533003703,0.5213631283889322,0.9897340531605416,Downregulated
Feature0858,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,2270045.2567781466,3241512.6316767707,1.4279506639781352,0.5139461347846209,0.6313442355166449,0.9897340531605416,Upregulated
Feature0857,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,8740050.26226658,7660319.641863953,0.8764617378616062,-0.19023698371109934,0.2728337493543919,0.9897340531605416,Downregulated
Feature0856,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,46854972.643469565,47763718.754003465,1.0193948701549516,0.027712998378849427,0.9021655363604488,0.9897340531605416,Upregulated
Feature0855,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,209926.53000402398,176647.43426117,0.8414726535887768,-0.24901170767310127,0.47433656988138423,0.9897340531605416,Downregulated
Feature0854,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4851848.11400986,4686995.007218753,0.9660226159357527,-0.049871129929398586,0.9083044876136466,0.9897340531605416,Downregulated
Feature0853,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,3021196.0338315233,3095165.198561357,1.0244834045528732,0.034896614546145635,0.934856227632171,0.9897340531605416,Upregulated
Feature0852,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,3585310.399330277,5796770.097118677,1.6168112245459954,0.6931512426273124,0.5121684059769744,0.9897340531605416,Upregulated
Feature0851,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,2676162.29547632,5418900.009288863,2.02487719763811,1.0178344157845771,0.6003625552808932,0.9897340531605416,Upregulated
Feature0850,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Phenol,9137520.46373254,8023286.24536665,0.8780594557584451,-0.18760946307238233,0.1556347435210347,0.9897340531605416,Downregulated
Feature0849,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Phenol,379449.6960157727,620789.5355359997,1.6360259134591457,0.7101955996995413,0.2742102699149252,0.9897340531605416,Upregulated
Feature0848,NA,C18 H33 N O15,503.18514,NA,NA,Feature0848,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,2774357.0117483465,3050655.4683274333,1.0995900871477853,0.13696580606390935,0.23218051801448028,0.9897340531605416,Upregulated
Feature0847,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,12435767.74014322,13525830.201452687,1.0876554213690157,0.12122157072423065,0.7819567164307272,0.9897340531605416,Upregulated
Feature0846,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,14216150.937672967,7636208.491670096,0.5371502121178282,-0.8966025057948795,0.193133180575345,0.9897340531605416,Downregulated
Feature0845,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,293618.59999279934,2383722.1190462443,8.118430232637518,3.0212007970503354,0.42400669422744,0.9897340531605416,Upregulated
Feature0844,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Phenol,1052772.962359587,10502887.65240601,9.976403296742937,3.318519787385961,0.43215248986508437,0.9897340531605416,Upregulated
Feature0843,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature0843,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,544509.638434968,365779.8417394737,0.671760086361005,-0.5739820166708672,0.12902403047862493,0.9897340531605416,Downregulated
Feature0842,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Phenol,20629457.513230734,19583983.8749727,0.949321321824022,-0.07503160833666209,0.8317262618049001,0.9897340531605416,Downregulated
Feature0841,NA,C14 H31 N O,229.24056,NA,NA,Feature0841,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,33084879.8868149,15032457.913376492,0.4543603593183144,-1.1380911225217891,0.1244440624683433,0.9897340531605416,Downregulated
Feature0840,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,2063436.5024424433,1480063.33412721,0.7172807752384396,-0.47939013111770956,0.4683151314756246,0.9897340531605416,Downregulated
Feature0839,NA,C12 H19 N O7,289.11624,NA,NA,Feature0839,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,1287638.72386649,1999328.1722127367,1.5527089510085585,0.6347874277368365,0.3162747559952359,0.9897340531605416,Upregulated
Feature0838,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,12811483.093814684,11084011.95528993,0.8651622824715144,-0.20895732380547422,0.7317934516655213,0.9897340531605416,Downregulated
Feature0837,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,3294905.8421347835,3021361.807518043,0.9169797111897103,-0.12503828133944683,0.7390368201749553,0.9897340531605416,Downregulated
Feature0836,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature0836,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Phenol,1576068.33382196,1684380.1629251933,1.068722800134292,0.09588770270195117,0.7118501046570606,0.9897340531605416,Upregulated
Feature0835,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,321266.2143279758,2479209.4595513074,7.716994034798567,2.948038990549675,0.4600907311312555,0.9897340531605416,Upregulated
Feature0834,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature0834,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,4743821.75227725,4677695.4334492935,0.9860605388901441,-0.020251871737059553,0.9420997939175209,0.9897340531605416,Downregulated
Feature0833,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,32335702.876394067,34361204.8545958,1.062639800530837,0.0876526542055086,0.7933978556036685,0.9897340531605416,Upregulated
Feature0832,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,2866914.9952669637,2237841.8028747966,0.7805748710963826,-0.3573910757796936,0.7264056403300285,0.9897340531605416,Downregulated
Feature0831,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,11894381.996793913,16301625.080180204,1.3705314899567078,0.4547354765638788,0.5014960257853796,0.9897340531605416,Upregulated
Feature0830,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,1854242.2382242733,1383156.9670459898,0.7459418939623438,-0.4228648404889929,0.48259306032922966,0.9897340531605416,Downregulated
Feature0829,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature0829,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,276676.7262548457,292839.74311233463,1.0584184187671835,0.08191007295831149,0.8606857269164618,0.9897340531605416,Upregulated
Feature0828,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,10705556.7630738,11124914.041993989,1.0391719261502268,0.05543436115734775,0.922645693436609,0.9897340531605416,Upregulated
Feature0827,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,11672789.1636994,11986315.74633407,1.0268596115493709,0.03823895520431239,0.954222871960527,0.9968697042269192,Upregulated
Feature0826,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,955507.8760638126,1221771.1105456934,1.2786614753807626,0.3546343623948201,0.229160651360761,0.9897340531605416,Upregulated
Feature0825,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,372097.6800791257,838918.4175298534,2.2545650307506873,1.1728491237205843,0.5486545439254358,0.9897340531605416,Upregulated
Feature0824,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,26826173.0728536,28143678.7443,1.049112695570418,0.06916966038211074,0.9089196896043614,0.9897340531605416,Upregulated
Feature0823,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Phenol,12126502.34338849,11244520.548666991,0.9272682452246945,-0.10894134495366124,0.8463796425690991,0.9897340531605416,Downregulated
Feature0822,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,13015484.20381825,10762167.478986543,0.8268741531589989,-0.27426032102764375,0.8065568782404178,0.9897340531605416,Downregulated
Feature0821,NA,C12 H19 N O8,305.11113,NA,NA,Feature0821,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,16466209.827336933,15053212.087338533,0.9141880399427096,-0.12943715018322938,0.6954569192063991,0.9897340531605416,Downregulated
Feature0820,NA,C18 H33 N O15,503.18519,NA,NA,Feature0820,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,11565165.890241833,11182672.455595,0.9669271121333793,-0.048520952782923815,0.6160035235052501,0.9897340531605416,Downregulated
Feature0819,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,7611059.2013070695,8734807.725681862,1.1476467985141685,0.1986787043517668,0.8231549349021878,0.9897340531605416,Upregulated
Feature0818,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,25214202.383601833,26769729.831365567,1.0616925105977326,0.08636599055858327,0.8225659013137262,0.9897340531605416,Upregulated
Feature0817,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Phenol,5122669.962106023,6546814.000847423,1.2780081577138944,0.3538970452487716,0.537327388130742,0.9897340531605416,Upregulated
Feature0816,NA,C7 H17 N O6,211.10558,NA,NA,Feature0816,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,6337937.273637567,6388103.26537863,1.007915192210836,0.01137425300036906,0.9741152632439073,0.9990212121416295,Upregulated
Feature0815,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Phenol,28478719.232754666,22661501.325608134,0.7957345672885497,-0.32964082280898654,0.41604829292354095,0.9897340531605416,Downregulated
Feature0814,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,17068127.552935068,21587768.938823234,1.264800070884809,0.3389093536637282,0.07466766577222601,0.9897340531605416,Upregulated
Feature0813,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,1481424.8751327521,739886.443818139,0.4994424329157002,-1.0016096962154912,0.20916291984386023,0.9897340531605416,Downregulated
Feature0812,NA,C32 H36 O10,580.23105,NA,NA,Feature0812,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,236666.370179821,198436.302096711,0.8384642986916033,-0.25417873888201153,0.4508306396887363,0.9897340531605416,Downregulated
Feature0811,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,1292215.0674037763,1003636.3270717527,0.7766790160465975,-0.3646096064670842,0.3569837577055618,0.9897340531605416,Downregulated
Feature0810,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Phenol,251662.93935451,1120762.1497285364,4.45342549285635,2.15491545752707,0.41579465953371664,0.9897340531605416,Upregulated
Feature0809,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,1019691.7528754696,650377.0558032097,0.6378173148593046,-0.6487848318494277,0.022767816301851023,0.9897340531605416,Downregulated
Feature0808,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature0808,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,330004.43827884266,283873.85316328134,0.8602122281865114,-0.2172354550967221,0.5224627806260054,0.9897340531605416,Downregulated
Feature0807,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,1831382.0467527534,1820397.93711779,0.994002283873843,-0.008678928281207256,0.9473552983562246,0.9916527924740266,Downregulated
Feature0806,NA,C9 H19 N O3,189.13649,NA,NA,Feature0806,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,1312925.75995004,1063442.8364143374,0.8099794130437383,-0.3040428548865796,0.290389328081968,0.9897340531605416,Downregulated
Feature0805,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,218190.857686151,225444.09923811132,1.0332426465016857,0.04717909621349138,0.9123758174436336,0.9897340531605416,Upregulated
Feature0804,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,24967616.7253616,26037070.914529532,1.042833651322499,0.06050904323425615,0.9204987354425476,0.9897340531605416,Upregulated
Feature0803,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,4266210.768788647,3578093.2992470097,0.8387052335585796,-0.25376423631268724,0.6399343412639154,0.9897340531605416,Downregulated
Feature0802,NA,C11 H17 N O5,243.11065,NA,NA,Feature0802,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,1797049.6162449638,1180721.515124986,0.6570333420132105,-0.6059615110420664,0.28789580766036216,0.9897340531605416,Downregulated
Feature0801,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,6598305.85649967,9204243.84909374,1.3949404664270129,0.4802035517151947,0.49858374974189107,0.9897340531605416,Upregulated
Feature0800,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,1072683.08535976,997012.570741465,0.9294567839736967,-0.10554030773751472,0.8804628047229845,0.9897340531605416,Downregulated
Feature0799,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,36138508.10698517,32856011.4025487,0.9091690034707881,-0.1373795960607595,0.5470570169427942,0.9897340531605416,Downregulated
Feature0798,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Phenol,13821811.837702902,14700263.26269568,1.0635554466597898,0.08889524771883595,0.8903798225995917,0.9897340531605416,Upregulated
Feature0797,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,2024721.1986163668,3440785.762150233,1.6993874339348853,0.7650148020782502,0.4578293904825462,0.9897340531605416,Upregulated
Feature0796,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1303957.775935771,2904078.95746224,2.2271265305183365,1.1551835247919495,0.2703903765330777,0.9897340531605416,Upregulated
Feature0795,NA,C7 H17 N O6,211.10569,NA,NA,Feature0795,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,5632350.034322296,3010351.64811494,0.534475242087321,-0.9038049737799456,0.4510675202541286,0.9897340531605416,Downregulated
Feature0794,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,4805893.76977429,3045850.189445983,0.6337739316258404,-0.6579597748446753,0.4241807575599306,0.9897340531605416,Downregulated
Feature0793,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,13317533.9336793,12804030.783314867,0.9614415737236598,-0.056728906443614405,0.8312052590800785,0.9897340531605416,Downregulated
Feature0792,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,2576210.94529568,2362348.2993065165,0.916985584437606,-0.12502904091855854,0.7840258424674406,0.9897340531605416,Downregulated
Feature0791,NA,C15 H27 N O5,301.18898,NA,NA,Feature0791,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,929788.2121723803,1478142.0823381676,1.5897621232308374,0.6688109105981287,0.287414443032557,0.9897340531605416,Upregulated
Feature0790,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Phenol,14760556.075276956,8085125.052688209,0.5477520637742306,-0.868405079996394,0.3809545787291579,0.9897340531605416,Downregulated
Feature0789,NA,C31 H40 O6,508.28264,NA,NA,Feature0789,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Phenol,124518.67941910363,108229.41824021643,0.8691821881272851,-0.20226948475350265,0.5353668727253837,0.9897340531605416,Downregulated
Feature0788,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Phenol,1563170.4545707565,1222215.3361412433,0.7818823165237352,-0.3549766154162627,0.36226134721755837,0.9897340531605416,Downregulated
Feature0787,NA,C6 H9 O7 P,224.00856,NA,NA,Feature0787,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,7797635.931120917,6783570.853373577,0.8699522410760248,-0.2009918932984481,0.7442793438497435,0.9897340531605416,Downregulated
Feature0786,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,14703527.806579923,16001527.990396334,1.0882781466387643,0.12204733369442325,0.9216652325858017,0.9897340531605416,Upregulated
Feature0785,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,3373647.2195300334,5993882.86656008,1.7766774284701468,0.8291817710738892,0.26649612669108885,0.9897340531605416,Upregulated
Feature0784,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,14928513.786525933,16074979.82015075,1.0767970643306493,0.10674638185006967,0.8049390782245043,0.9897340531605416,Upregulated
Feature0783,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature0783,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,141454.04071053577,120570.74771261003,0.852366939162521,-0.23045345863121675,0.5196591958000188,0.9897340531605416,Downregulated
Feature0782,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,5744537.754030527,6756517.19294669,1.1761637719599163,0.2340889585960678,0.6290578722838132,0.9897340531605416,Upregulated
Feature0781,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature0781,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,32442671.63011433,27971459.2320213,0.8621811283278313,-0.2139371101554788,0.3849886189523724,0.9897340531605416,Downregulated
Feature0780,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Phenol,107819.1226927442,93529.0921120784,0.8674629302875281,-0.2051259872633614,0.3067241296351079,0.9897340531605416,Downregulated
Feature0779,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,6682971.596449307,4130628.66442646,0.6180826305802469,-0.6941283720337039,0.15673473558310874,0.9897340531605416,Downregulated
Feature0778,NA,C11 H14 N O P S,239.05347,NA,NA,Feature0778,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,194092.30749008767,177138.439514235,0.9126504898875578,-0.13186562574605046,0.5443506411453336,0.9897340531605416,Downregulated
Feature0777,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,29136705.151380602,22075894.627583466,0.7576661298141815,-0.4003658388021211,0.04036303286140384,0.9897340531605416,Downregulated
Feature0776,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature0776,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,28262747.3261123,23264555.660140336,0.8231526606985559,-0.28076807929693237,0.47226337592434026,0.9897340531605416,Downregulated
Feature0775,NA,C4 H11 O6 P,186.02935,NA,NA,Feature0775,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,17776676.7961467,22086071.895923045,1.2424184873918875,0.31315120253759,0.6801647288801723,0.9897340531605416,Upregulated
Feature0774,NA,C13 H19 N O6,285.1213,NA,NA,Feature0774,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Phenol,408357.8557775607,385454.4205966643,0.9439133229424824,-0.08327370807810872,0.8727816241139379,0.9897340531605416,Downregulated
Feature0773,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,11197864.309641046,9861014.23569472,0.8806156212488361,-0.1834156584045868,0.7279972973238733,0.9897340531605416,Downregulated
Feature0772,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,6092711.411056063,6550811.1604657965,1.075188158194798,0.10458915389921464,0.8832466769062333,0.9897340531605416,Upregulated
Feature0771,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Phenol,861902.5394135483,455897.351520431,0.5289430424820776,-0.9188157161259815,0.4002932910215529,0.9897340531605416,Downregulated
Feature0770,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,16660753.662814101,16847572.7871343,1.0112131256545236,0.016087095085121263,0.9136224651499021,0.9897340531605416,Upregulated
Feature0769,Furan,C4 H4 O,68.02622,Other,NA,Furan,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,17518109.857934933,16561721.430620868,0.9454057295524457,-0.08099448683153145,0.6622244014600006,0.9897340531605416,Downregulated
Feature0768,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,3339707.04269075,3679545.8967110734,1.1017570851802978,0.13980617432954218,0.8575915248164524,0.9897340531605416,Upregulated
Feature0767,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,2634344.0597624667,3082401.19746701,1.1700829988566277,0.2266108698017185,0.40600049056950127,0.9897340531605416,Upregulated
Feature0766,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,1328506.0702837142,1375795.13645747,1.035595671884026,0.050460840836853094,0.9201396947507627,0.9897340531605416,Upregulated
Feature0765,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,1591202.1506800633,1803619.16113647,1.133494672795422,0.18077761070844156,0.5313777158387522,0.9897340531605416,Upregulated
Feature0764,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Phenol,2444567.2781775966,6827245.4395547295,2.7928237036063006,1.4817245066789486,0.46086765053809703,0.9897340531605416,Upregulated
Feature0763,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,6285503.032914303,6939502.444853303,1.104048857905931,0.14280401767670367,0.4654506227330205,0.9897340531605416,Upregulated
Feature0762,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3784513.43723092,7780355.70964969,2.0558404240579145,1.0397282857599202,0.44628456699040664,0.9897340531605416,Upregulated
Feature0761,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Phenol,236296.111644129,457681.4745985093,1.9368980361716452,0.9537480083648103,0.14362528561130866,0.9897340531605416,Upregulated
Feature0760,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,916860.9060775621,617817.514379709,0.6738399579308102,-0.5695221137423451,0.6708975127276373,0.9897340531605416,Downregulated
Feature0759,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,3897084.6737683634,6833118.935649773,1.7533924735185067,0.8101489602866973,0.2596970495327713,0.9897340531605416,Upregulated
Feature0758,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Phenol,515795.7749504643,443533.65102597966,0.8599016753647807,-0.21775638922763982,0.4561265196725115,0.9897340531605416,Downregulated
Feature0757,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,2382628.6344733573,2959309.341912067,1.2420354977250476,0.3127064067790464,0.8294964017067313,0.9897340531605416,Upregulated
Feature0756,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4440859.277566744,3121507.6888558334,0.7029062381292532,-0.5085958363256603,0.3331973872452265,0.9897340531605416,Downregulated
Feature0755,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0755,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,1493870.2451069765,1612842.31246423,1.0796401613506492,0.11055054948292901,0.8088928849596828,0.9897340531605416,Upregulated
Feature0754,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,1475491.3273642699,3078963.825122144,2.0867380024674373,1.0612494762675129,0.5907050754100375,0.9897340531605416,Upregulated
Feature0753,NA,C18 H28 O,260.21405,NA,NA,Feature0753,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1240029.0918568387,937563.5889779644,0.7560819299602417,-0.4033855197757176,0.30178376668226525,0.9897340531605416,Downregulated
Feature0752,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Phenol,113898.21335687733,404875.54224717716,3.5547137247761773,1.829733378557525,0.4469855417170489,0.9897340531605416,Upregulated
Feature0751,NA,C13 H18 O9,318.09513,NA,NA,Feature0751,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,129324.37045032273,112967.7954579038,0.8735228717103868,-0.1950826167354088,0.57528668586408,0.9897340531605416,Downregulated
Feature0750,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,1547521.5076384866,5595848.408611143,3.6160068735654547,1.8543974201340105,0.4232881077742389,0.9897340531605416,Upregulated
Feature0749,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,4221423.178315717,4660120.323028526,1.1039216222070025,0.14263774524351236,0.802363694468273,0.9897340531605416,Upregulated
Feature0748,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,24838710.78778953,24598235.447362132,0.9903185256883134,-0.014035467149057615,0.9332874706883574,0.9897340531605416,Downregulated
Feature0747,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature0747,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,14902379.955123367,16482854.203697713,1.106055157185211,0.14542333223934883,0.7785858102305898,0.9897340531605416,Upregulated
Feature0746,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature0746,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,4308041.204835377,6361736.118373207,1.4767119941268778,0.5623884820535577,0.4171482469249734,0.9897340531605416,Upregulated
Feature0745,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,12078440.377236757,16045059.230228337,1.32840488747762,0.4096949359378672,0.6486828770885299,0.9897340531605416,Upregulated
Feature0744,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Phenol,608647.0139041137,756990.2641090499,1.2437262433169618,0.3146689686905464,0.7494437412329378,0.9897340531605416,Upregulated
Feature0743,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,315270.571792814,357384.50112217234,1.1335802738894205,0.18088655838486975,0.7296767608342347,0.9897340531605416,Upregulated
Feature0742,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,220462.283964317,277688.17131375935,1.259572233038757,0.33293385907783823,0.36263847245750014,0.9897340531605416,Upregulated
Feature0741,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,7351443.086696863,7043574.363127827,0.9581213212238351,-0.06171974743734953,0.901927808669862,0.9897340531605416,Downregulated
Feature0740,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Phenol,4370130.769517093,5791188.958090293,1.325175209512147,0.40618311981407373,0.16948230149819704,0.9897340531605416,Upregulated
Feature0739,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,228413.328176365,2262057.9695681804,9.903353659912417,3.307917160466233,0.44851455770357157,0.9897340531605416,Upregulated
Feature0738,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1014774.285664735,805036.9843727336,0.7933163026942376,-0.33403189813200673,0.31470584642674676,0.9897340531605416,Downregulated
Feature0737,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,2333354.562866962,4079169.8711204715,1.7481997532807227,0.8058700398743502,0.6787983897447235,0.9897340531605416,Upregulated
Feature0736,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,10446262.820064576,8335281.773517974,0.7979199755062688,-0.3256840310580734,0.041119732947912706,0.9897340531605416,Downregulated
Feature0735,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,7631480.8622159995,6140703.629776293,0.804654265750616,-0.31355905852791033,0.26505235672861077,0.9897340531605416,Downregulated
Feature0734,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,2426433.2839538935,4705023.048395374,1.9390696127974716,0.9553645972739724,0.45074022509602674,0.9897340531605416,Upregulated
Feature0733,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0733,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,21809632.7863606,18416565.7432832,0.844423467542316,-0.24396142141728597,0.24147952537350262,0.9897340531605416,Downregulated
Feature0732,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,747892.8203202327,783323.288669027,1.0473737243975998,0.06677631727361497,0.8882665659457727,0.9897340531605416,Upregulated
Feature0731,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,17722084.145549603,10687447.546478337,0.6030581650952258,-0.7296309377909922,0.08882524776298964,0.9897340531605416,Downregulated
Feature0730,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,7337734.422690333,7676788.141952987,1.0462068670970435,0.06516814472741472,0.8020134341651957,0.9897340531605416,Upregulated
Feature0729,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,871435.9750904327,858068.4502875,0.9846603477650261,-0.02230193285539884,0.9410968257518738,0.9897340531605416,Downregulated
Feature0728,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,3941691.88111353,4609928.84525909,1.1695304920578375,0.22592947619838616,0.8317337856811731,0.9897340531605416,Upregulated
Feature0727,NA,C29 H30 O10,538.18408,NA,NA,Feature0727,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,350238.05621094664,297470.56097120664,0.8493382021057174,-0.23558895295389617,0.5094575368620873,0.9897340531605416,Downregulated
Feature0726,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Phenol,10139235.926685331,9360554.83928095,0.9232012063793702,-0.11528298568256562,0.837108568377389,0.9897340531605416,Downregulated
Feature0725,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,29180957.838676333,23950120.179251768,0.8207448265289073,-0.2849943439235419,0.3906813933169082,0.9897340531605416,Downregulated
Feature0724,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,2487793.50721406,2351500.4661344355,0.9452152919105206,-0.08128512513441101,0.8860151924672894,0.9897340531605416,Downregulated
Feature0723,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Phenol,5270894.486921307,4657080.150507417,0.8835464572593987,-0.17862210057945677,0.6528493070126535,0.9897340531605416,Downregulated
Feature0722,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,7811031.380019766,10707783.294720143,1.3708539594540774,0.4550748853448941,0.3517053134352001,0.9897340531605416,Upregulated
Feature0721,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,3734909.36480916,4611421.460903517,1.234680954872152,0.30413829339852877,0.5458766358771687,0.9897340531605416,Upregulated
Feature0720,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,24118215.4354955,24050393.845839698,0.9971879515780431,-0.004062643168675427,0.9803454911948954,0.9990212121416295,Downregulated
Feature0719,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,5413932.1547114635,6546172.628618924,1.209134588604353,0.27397483971120845,0.5855390491595945,0.9897340531605416,Upregulated
Feature0718,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature0718,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,22886068.3715825,14202363.623711033,0.6205680850515166,-0.6883385919006276,0.06207455268204754,0.9897340531605416,Downregulated
Feature0717,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,8378278.696594346,5450428.45561921,0.6505427490535417,-0.6202842311477981,0.5112700746036264,0.9897340531605416,Downregulated
Feature0716,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,125112.40155444543,132496.82295982738,1.0590222976590251,0.08273296551857919,0.8184239460414968,0.9897340531605416,Upregulated
Feature0715,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature0715,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,10723948.2145859,11917654.581504386,1.1113122091819594,0.15226418068948971,0.4387437388871067,0.9897340531605416,Upregulated
Feature0714,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,6239692.193596397,5615152.23429353,0.8999085307535181,-0.1521497255945756,0.6445255970598974,0.9897340531605416,Downregulated
Feature0713,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,195682.74058957933,513663.7657221327,2.6249824801844928,1.392307793889123,0.18892502323399807,0.9897340531605416,Upregulated
Feature0712,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,10078426.742309617,9735185.344254216,0.9659429584763999,-0.04999009832424504,0.881074356132671,0.9897340531605416,Downregulated
Feature0711,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,23624802.308456134,22756706.8437802,0.9632549109473305,-0.05401045871439887,0.7414020187919038,0.9897340531605416,Downregulated
Feature0710,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,26413015.1336038,24773930.436455198,0.9379440518676989,-0.09242622598500205,0.6648768433473028,0.9897340531605416,Downregulated
Feature0709,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature0709,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,1103364.169572668,873318.499975653,0.7915052201793797,-0.33732922955071915,0.661804382083608,0.9897340531605416,Downregulated
Feature0708,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1435147.563337297,2275232.24733405,1.585364672914343,0.6648147339237321,0.24984043093535166,0.9897340531605416,Upregulated
Feature0707,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,3939991.98210936,4436643.85128455,1.1260540304219848,0.17127605259730486,0.6776048726331888,0.9897340531605416,Upregulated
Feature0706,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,6942308.60078755,7467218.16960185,1.0756102327048316,0.1051553853162589,0.7915451887203764,0.9897340531605416,Upregulated
Feature0705,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Phenol,583837.9129803313,771007.3812261369,1.3205846418749292,0.4011767729171807,0.1535604834966702,0.9897340531605416,Upregulated
Feature0704,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature0704,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,13801411.456524476,7373516.68808864,0.5342581598495048,-0.9043910572160994,0.562239042564328,0.9897340531605416,Downregulated
Feature0703,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Phenol,168770.16621850934,153756.38272443533,0.9110400621716789,-0.13441359824138305,0.7339865162421757,0.9897340531605416,Downregulated
Feature0702,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,559810.9722604023,629473.0908310494,1.1244386445113173,0.16920494197459895,0.6939099342783823,0.9897340531605416,Upregulated
Feature0701,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,6844491.322364833,9433432.167970534,1.3782517536615415,0.4628394370881571,0.35135267405400245,0.9897340531605416,Upregulated
Feature0700,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Phenol,2162376.111941113,2169038.6605487233,1.0030811238483528,0.00443828814443648,0.9938992497844978,0.9990212121416295,Upregulated
Feature0699,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,3580392.5155365635,3264762.138748847,0.9118447557305276,-0.1331398726929615,0.8036513626967043,0.9897340531605416,Downregulated
Feature0698,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature0698,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,1266239.8441197986,1325028.615526007,1.0464278325146799,0.06547281874765906,0.8454581988505765,0.9897340531605416,Upregulated
Feature0697,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,136229.435832708,95219.17827043243,0.698961848358259,-0.5167143841886231,0.10775012998006286,0.9897340531605416,Downregulated
Feature0696,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature0696,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Phenol,532053.1025504853,456393.01019926666,0.8577959756488039,-0.22129354730411524,0.5117621472595291,0.9897340531605416,Downregulated
Feature0695,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,2850178.88748823,2264606.98250473,0.7945490693394528,-0.3317917753681016,0.5919500603344346,0.9897340531605416,Downregulated
Feature0694,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Phenol,21642212.711967766,22062406.218262933,1.0194154595875868,0.027742137207435204,0.9154131352826603,0.9897340531605416,Upregulated
Feature0693,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,4988757.33030108,9035745.89557853,1.811221772744197,0.8569632060614082,0.5016000747597703,0.9897340531605416,Upregulated
Feature0692,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature0692,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,790433.719977719,769234.46373682,0.973180222825645,-0.03922109306692226,0.9474614915616368,0.9916527924740266,Downregulated
Feature0691,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Phenol,249819.42975307832,188352.565272576,0.7539548283283802,-0.40745000494624506,0.3436152633420312,0.9897340531605416,Downregulated
Feature0690,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,3900834.4300859496,2510688.8802485066,0.6436286710567172,-0.6356995011596905,0.25302448359936797,0.9897340531605416,Downregulated
Feature0689,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,7307706.353234463,6932715.84428308,0.9486856079287574,-0.0759980340161908,0.813993734800038,0.9897340531605416,Downregulated
Feature0688,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,17648733.963040866,14068768.708755367,0.7971545572740519,-0.3270686248809838,0.14713998784583793,0.9897340531605416,Downregulated
Feature0687,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature0687,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,474686.30055668805,1834797.0731664407,3.865283390345758,1.9505741918625297,0.3566139431623412,0.9897340531605416,Upregulated
Feature0686,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature0686,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Phenol,20422361.007440433,20113311.181600567,0.9848670863409343,-0.021999057440561957,0.8928965777648371,0.9897340531605416,Downregulated
Feature0685,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,4287062.905616663,5241514.03636438,1.2226352054450262,0.28999401482106657,0.29109003735661154,0.9897340531605416,Upregulated
Feature0684,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3590723.407071347,8057834.612808401,2.2440699823717427,1.1661176677677192,0.4707898132880716,0.9897340531605416,Upregulated
Feature0683,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Phenol,235851.05119322732,195650.51047437201,0.8295511488480926,-0.2695971566061791,0.45102551297233595,0.9897340531605416,Downregulated
Feature0682,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,8648866.601740938,7874295.095561187,0.910442426522819,-0.13536030623683126,0.7719052228607306,0.9897340531605416,Downregulated
Feature0681,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Phenol,2759233.0086197634,2951385.12128559,1.0696396832255735,0.09712489497428566,0.5782353082544915,0.9897340531605416,Upregulated
Feature0680,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Phenol,1978590.4267642633,1667112.3448424567,0.8425757662078706,-0.24712167254819986,0.6922660711563566,0.9897340531605416,Downregulated
Feature0679,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,9954772.373984937,5648946.48930456,0.5674611409565826,-0.8174064930894627,0.4812338505948283,0.9897340531605416,Downregulated
Feature0678,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,9902845.924888054,9391461.67336344,0.9483598699400754,-0.0764934787390524,0.8369256142262448,0.9897340531605416,Downregulated
Feature0677,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0677,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,133108.22366005316,123831.82790618467,0.93030937158654,-0.10421753497550426,0.8341426921442705,0.9897340531605416,Downregulated
Feature0676,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,18918793.890794165,13539785.367379019,0.7156790990765771,-0.48261524754915447,0.21271761972376732,0.9897340531605416,Downregulated
Feature0675,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,6387627.131099683,6284802.737155886,0.9839025679123987,-0.023412636791517276,0.93960768860048,0.9897340531605416,Downregulated
Feature0674,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,408881.6069422947,267935.77257757867,0.6552893747930127,-0.6097959555867524,0.2953203100938831,0.9897340531605416,Downregulated
Feature0673,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0673,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,12823097.24551199,11659537.939293236,0.9092606658172234,-0.1372341509935304,0.6967179080205694,0.9897340531605416,Downregulated
Feature0672,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,6553007.200203817,12517067.868849713,1.910125761567971,0.9336676275895623,0.4089725882303799,0.9897340531605416,Upregulated
Feature0671,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,645189.9556541783,395922.1056907603,0.6136519984867441,-0.7045073584928907,0.12787536412015166,0.9897340531605416,Downregulated
Feature0670,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,9122457.698245954,13933935.569236003,1.5274321931813606,0.6111083363567348,0.5232994925249121,0.9897340531605416,Upregulated
Feature0669,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,10515573.760662444,10897317.271623842,1.036302680162775,0.05144544259224465,0.8536540866371918,0.9897340531605416,Upregulated
Feature0668,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0668,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Phenol,8121275.46531626,11982745.191665856,1.4754757725976508,0.5611802318236752,0.24632806437235855,0.9897340531605416,Upregulated
Feature0667,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0667,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,2184497.9282775465,3119518.8232175135,1.4280255352209106,0.5140217771311589,0.5309562860467991,0.9897340531605416,Upregulated
Feature0666,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0666,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,2916871.1529228534,2255850.32746448,0.7733801766334462,-0.37075030931218805,0.4148875445036854,0.9897340531605416,Downregulated
Feature0665,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0665,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,4744707.14027695,5229471.893022067,1.102169583582944,0.14034621898280208,0.7607089717231639,0.9897340531605416,Upregulated
Feature0664,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,17644129.076620165,17993476.06342523,1.0197996163646286,0.02828570035607406,0.9463831890813351,0.9916527924740266,Upregulated
Feature0663,NA,C9 H19 N O9,285.106,NA,NA,Feature0663,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,12113336.061901763,11288005.892318197,0.9318659892397972,-0.1018055976905153,0.8975515381767276,0.9897340531605416,Downregulated
Feature0662,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0662,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,8503210.892765714,8572958.48335077,1.008202500380697,0.011785437403138966,0.979790409501053,0.9990212121416295,Upregulated
Feature0661,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,587051.396003852,1538721.3839182719,2.6211016520743873,1.3901733056311592,0.4530364674914754,0.9897340531605416,Upregulated
Feature0660,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,1277346.0278490388,905349.0892929134,0.7087735582639716,-0.4966033116391838,0.6872555481471763,0.9897340531605416,Downregulated
Feature0659,NA,C19 H41 N O2,315.3138,NA,NA,Feature0659,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,10468141.230016967,11285048.22275097,1.0780374447367556,0.10840728977670842,0.9414052036577358,0.9897340531605416,Upregulated
Feature0658,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,17762838.367039565,14623445.966983465,0.8232606560288526,-0.28057881415178476,0.4340034065423602,0.9897340531605416,Downregulated
Feature0657,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0657,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,91068.72825440357,450386.7559571444,4.94556984148251,2.3061367616550443,0.40531291649208956,0.9897340531605416,Upregulated
Feature0656,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,4688827.501723477,11631925.055107508,2.480774788757307,1.3107907695347847,0.36472061408106665,0.9897340531605416,Upregulated
Feature0655,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Phenol,19044403.423702918,16038756.87658077,0.8421769125421235,-0.2478047689143573,0.6610272811368039,0.9897340531605416,Downregulated
Feature0654,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,12492891.547885787,14399987.672671236,1.1526545009596432,0.20496014139569443,0.6025753876596056,0.9897340531605416,Upregulated
Feature0653,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,8574328.52546854,8144937.141924493,0.9499212816177249,-0.07412013020708491,0.8067437562894737,0.9897340531605416,Downregulated
Feature0652,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,468135.9463201237,558193.7689451124,1.1923753630391047,0.25383847166236156,0.4876075853079514,0.9897340531605416,Upregulated
Feature0651,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,1389875.340454139,1267484.28196927,0.911940981379756,-0.13298763521873175,0.6354395015424499,0.9897340531605416,Downregulated
Feature0650,NA,C19 H41 N O2,315.31381,NA,NA,Feature0650,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,613553.4000021043,467576.2881280047,0.7620792063517227,-0.39198714353057634,0.7855954334402823,0.9897340531605416,Downregulated
Feature0649,NA,C12 H21 N O8,307.12685,NA,NA,Feature0649,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1924661.2072642033,7022770.244269364,3.6488345157908766,1.8674357224045588,0.3440911279080433,0.9897340531605416,Upregulated
Feature0648,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0648,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,846638.741824212,919545.722532501,1.0861134473378808,0.11917480421372374,0.8229187278924693,0.9897340531605416,Upregulated
Feature0647,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,693819.6620670717,920453.4721314413,1.3266465660387425,0.40778407128200445,0.5916864200182617,0.9897340531605416,Upregulated
Feature0646,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0646,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Phenol,13494698.382192133,11668396.608240433,0.8646652394719897,-0.20978640240569424,0.24009761292800427,0.9897340531605416,Downregulated
Feature0645,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,470695.82868840767,536248.811009247,1.1392682457023307,0.18810747591422153,0.8376666698234325,0.9897340531605416,Upregulated
Feature0644,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0644,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,64807.40285344517,66661.75198531977,1.0286132301284778,0.04070061501338603,0.9304609205279939,0.9897340531605416,Upregulated
Feature0643,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,3715751.6916134236,4894284.792281307,1.3171721897692659,0.3974439568989809,0.4266992187035913,0.9897340531605416,Upregulated
Feature0642,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,11436717.947954936,12586067.0443688,1.100496410040381,0.13815443898195812,0.378345191904405,0.9897340531605416,Upregulated
Feature0641,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,16654300.723371867,17122741.5781095,1.0281273205353043,0.04001893508714734,0.9277107896218338,0.9897340531605416,Upregulated
Feature0640,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Phenol,412281.687027684,267373.96878495236,0.6485225446528229,-0.6247713669894412,0.16076698322886113,0.9897340531605416,Downregulated
Feature0639,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0639,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,8962343.969523087,7963650.790832587,0.8885678588004869,-0.17044613763552977,0.3717932757894987,0.9897340531605416,Downregulated
Feature0638,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0638,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,4671421.372515197,3690723.7347141034,0.7900644023313478,-0.3399578350950368,0.5237348287050542,0.9897340531605416,Downregulated
Feature0637,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Phenol,717814.9429298594,2058187.4277330074,2.8672953217332524,1.5196905049474452,0.4810148504459295,0.9897340531605416,Upregulated
Feature0636,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0636,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Phenol,1948355.5959330467,1875127.5125820134,0.9624154422817437,-0.05526830365708279,0.8201078486433415,0.9897340531605416,Downregulated
Feature0635,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,271981.0981380763,564079.0304321293,2.0739640890256426,1.0523909139037169,0.19631596706057067,0.9897340531605416,Upregulated
Feature0634,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,609039.27083733,1005666.8061649684,1.651234746787904,0.7235452346983942,0.5688407373783989,0.9897340531605416,Upregulated
Feature0633,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,18981113.537466798,16739575.629438067,0.881906933246874,-0.18130167723096693,0.47198837715784925,0.9897340531605416,Downregulated
Feature0632,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,3821712.802969597,3091193.70653724,0.8088503416937245,-0.3060553035666663,0.3877584151062808,0.9897340531605416,Downregulated
Feature0631,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0631,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,167289.71586401068,137678.26722603134,0.8229930125408881,-0.2810479131048641,0.3700189306518687,0.9897340531605416,Downregulated
Feature0630,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,3215192.1220878633,1286441.4232805467,0.40011339118521,-1.3215191805922626,0.12202156757308702,0.9897340531605416,Downregulated
Feature0629,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,5044453.85960488,7145791.61636292,1.4165639760500521,0.5023957593904882,0.5256627582633927,0.9897340531605416,Upregulated
Feature0628,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,3816791.5781159066,4249380.962819284,1.1133384875358894,0.15489228095295124,0.738832003017408,0.9897340531605416,Upregulated
Feature0627,NA,C15 H27 N O13,429.14831,NA,NA,Feature0627,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,4093391.1886706734,2202360.8544778596,0.5380284348521,-0.8942456735254183,0.5030080827129868,0.9897340531605416,Downregulated
Feature0626,NA,C6 H2 O4,137.99529,NA,NA,Feature0626,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,5556089.69188205,2988138.1157278544,0.5378131530334715,-0.8948230559575004,0.19959669418525405,0.9897340531605416,Downregulated
Feature0625,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0625,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Phenol,498002.491486697,562693.6084059486,1.1299011913095613,0.17619661596747963,0.5370589241032004,0.9897340531605416,Upregulated
Feature0624,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Phenol,498980.94933312165,589467.0286081326,1.1813417514154476,0.24042638365883698,0.5731071626491276,0.9897340531605416,Upregulated
Feature0623,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,6222915.88098755,4917960.842015553,0.7902984607330243,-0.3395304966581017,0.5158970018856778,0.9897340531605416,Downregulated
Feature0622,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0622,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4775383.665316587,5140613.645157876,1.0764818086751728,0.1063239397969576,0.8234345891083776,0.9897340531605416,Upregulated
Feature0621,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0621,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,111402.37201327336,92364.1700111814,0.8291041594713657,-0.2703747375411816,0.4164132877979345,0.9897340531605416,Downregulated
Feature0620,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,231558.07300432265,397238.517351155,1.715502777325926,0.7786314615592789,0.42882602600650904,0.9897340531605416,Upregulated
Feature0619,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0619,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,1843371.64344536,1919114.4470890302,1.0410892745979876,0.05809378669442237,0.8309823468327547,0.9897340531605416,Upregulated
Feature0618,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1008547.9255682023,827788.1189886604,0.8207722191509103,-0.28494619431702,0.6717177270779476,0.9897340531605416,Downregulated
Feature0617,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0617,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,9294466.23298083,9139242.369029557,0.9832993245593307,-0.024297442997255822,0.8356129851788111,0.9897340531605416,Downregulated
Feature0616,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,16741144.1519005,16727986.000161033,0.9992140231503847,-0.0011343707561905412,0.9954091897031929,0.9990212121416295,Downregulated
Feature0615,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,106112.41850963523,91010.7259160653,0.8576821374380543,-0.22148502024813047,0.45731168646053144,0.9897340531605416,Downregulated
Feature0614,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,928338.424214224,620974.3899135933,0.668909498644534,-0.5801170629278033,0.062380991854804765,0.9897340531605416,Downregulated
Feature0613,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1853611.8149563132,1608242.2872899934,0.8676262604249192,-0.20485437519730834,0.5459025748852675,0.9897340531605416,Downregulated
Feature0612,NA,C13 H27 N O11,373.15852,NA,NA,Feature0612,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,85755.15095546117,111345.37934439791,1.2984103940558345,0.3767464541303659,0.32781905485604623,0.9897340531605416,Upregulated
Feature0611,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,262987.049350979,1317807.328375355,5.010921000207228,2.3250757931042143,0.43028944545886483,0.9897340531605416,Upregulated
Feature0610,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,98783.5715934067,88799.66603208976,0.8989315186698179,-0.15371688063662195,0.5677228850279097,0.9897340531605416,Downregulated
Feature0609,NA,C12 H21 N O8,307.12682,NA,NA,Feature0609,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,15453838.867875699,12518464.335498532,0.810055316515626,-0.303907665732223,0.415959220777398,0.9897340531605416,Downregulated
Feature0608,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,231841.898763846,165645.04631262535,0.7144741619000942,-0.4850462559562243,0.4353937883933027,0.9897340531605416,Downregulated
Feature0607,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Phenol,3288055.93712647,4520815.7969480995,1.3749205863264526,0.4593482928033753,0.07641450076712947,0.9897340531605416,Upregulated
Feature0606,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,5596992.295959284,5059716.07554637,0.9040062605051651,-0.1455953311313236,0.8101664466469913,0.9897340531605416,Downregulated
Feature0605,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Phenol,299197.900972618,304497.73928462696,1.0177134876106433,0.025331463002880885,0.9241064588685515,0.9897340531605416,Upregulated
Feature0604,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,15751045.132732535,14206586.694685701,0.9019456534450996,-0.1488875880889132,0.6493838470957158,0.9897340531605416,Downregulated
Feature0603,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,198158.52062203933,165557.88181489566,0.8354820236606177,-0.259319307480231,0.5289660088317651,0.9897340531605416,Downregulated
Feature0602,NA,C12 H21 N O8,307.12679,NA,NA,Feature0602,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,740611.0280929847,2128998.152374683,2.8746508917868616,1.5233867604849942,0.5119435715637327,0.9897340531605416,Upregulated
Feature0601,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0601,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,10300685.30250945,11109363.7698669,1.0785072491400587,0.10903587354358327,0.3534070076004387,0.9897340531605416,Upregulated
Feature0600,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,319020.31972508965,389345.8649929364,1.2204422129864598,0.2874039862197949,0.6016280115143838,0.9897340531605416,Upregulated
Feature0599,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0599,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,12505588.2440842,8616395.004567446,0.6890035747533471,-0.5374166268118633,0.08062230052888962,0.9897340531605416,Downregulated
Feature0598,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1419090.7726021968,1330199.8189826806,0.9373606288366485,-0.09332389509387065,0.841043748375496,0.9897340531605416,Downregulated
Feature0597,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,153181.63200415613,107676.17722730387,0.7029313881731094,-0.5085442175001651,0.42453128881575636,0.9897340531605416,Downregulated
Feature0596,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,8125495.4503702605,7573751.877918203,0.9320972393841024,-0.10144762556640653,0.8098878541622199,0.9897340531605416,Downregulated
Feature0595,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,14006114.5046046,13914262.364177201,0.9934419970365655,-0.009492357941392913,0.9568716560892034,0.9977788086729426,Downregulated
Feature0594,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,470851.240851896,359927.42718030565,0.7644185593078199,-0.3875652889734693,0.5287932345670405,0.9897340531605416,Downregulated
Feature0593,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0593,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,6536083.813634723,7355917.682467443,1.1254319700005206,0.17047885154178255,0.42894558371476676,0.9897340531605416,Upregulated
Feature0592,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,14683395.109169256,12054909.527519614,0.8209892492773523,-0.2845647646209448,0.6802600322307122,0.9897340531605416,Downregulated
Feature0591,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,2902666.7578373533,2982569.5987987034,1.0275273903714948,0.03917685174290831,0.8662796971408802,0.9897340531605416,Upregulated
Feature0590,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0590,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,3776729.3046521298,2890783.1269199234,0.7654197306010498,-0.38567700434162266,0.5639028712132255,0.9897340531605416,Downregulated
Feature0589,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Phenol,103762.68748050806,672075.5081133458,6.477044151729358,2.6953355784592015,0.4049079999157237,0.9897340531605416,Upregulated
Feature0588,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3450519.9977902067,3285660.3280588402,0.9522217898064795,-0.07063045225012683,0.9010955448004594,0.9897340531605416,Downregulated
Feature0587,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,503510.02759201033,619841.7347324933,1.2310414902694757,0.29987938635307787,0.7430084924753955,0.9897340531605416,Upregulated
Feature0586,NA,C17 H29 N O14,471.15895,NA,NA,Feature0586,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,5153068.019323247,3551599.821649047,0.6892204427209325,-0.5369626014285024,0.4325885020140813,0.9897340531605416,Downregulated
Feature0585,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,1200765.5727047396,1894461.83446893,1.57771165124399,0.6578335568514612,0.09140035375070425,0.9897340531605416,Upregulated
Feature0584,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,873931.8498751316,552555.2406794783,0.6322635349180008,-0.6614020787757222,0.11019960912307425,0.9897340531605416,Downregulated
Feature0583,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,8560353.60426367,8515169.76078494,0.9947217316518064,-0.0076350993953257845,0.9919512036443783,0.9990212121416295,Downregulated
Feature0582,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,6356431.29656091,4941027.892424719,0.7773273495613834,-0.3634058178319898,0.11653563934226759,0.9897340531605416,Downregulated
Feature0581,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,11123276.667460684,10141782.29300138,0.9117621179620117,-0.13327062576329649,0.6751582954617383,0.9897340531605416,Downregulated
Feature0580,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,3141759.98650875,3701051.017643513,1.1780183825424138,0.23636205206808303,0.4565664865794947,0.9897340531605416,Upregulated
Feature0579,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2505546.53306775,1573536.2041799845,0.6280211456513533,-0.6711149589985606,0.17683692793456207,0.9897340531605416,Downregulated
Feature0578,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,13165100.2116255,12450221.811831133,0.9456989777287764,-0.0805470576738501,0.8529271100462446,0.9897340531605416,Downregulated
Feature0577,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0577,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,9518777.265962703,8391514.286556024,0.8815748128241689,-0.1818450891415773,0.10785274622285589,0.9897340531605416,Downregulated
Feature0576,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,326913.927583951,291252.953633574,0.8909163209596835,-0.16663816146313304,0.5252390000737508,0.9897340531605416,Downregulated
Feature0575,NA,C6 H11 N O7,209.05351,NA,NA,Feature0575,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,12361538.238522634,8659373.634298667,0.7005093918905012,-0.5135237015574378,0.3596582007041975,0.9897340531605416,Downregulated
Feature0574,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0574,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,11698433.863089656,11725973.177946266,1.0023541027097225,0.003392261004409918,0.9906731978280776,0.9990212121416295,Upregulated
Feature0573,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0573,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,13005959.940908534,11975050.857614513,0.920735640584942,-0.11914110226648655,0.5134496018046883,0.9897340531605416,Downregulated
Feature0572,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Phenol,329575.4710136077,295546.40269256366,0.896748783468661,-0.1572242118664474,0.6883386131375928,0.9897340531605416,Downregulated
Feature0571,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,9177017.585242087,9316794.68308373,1.0152312117246483,0.021808328417136032,0.9401339851681221,0.9897340531605416,Upregulated
Feature0570,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1396814.6582985525,1727319.7782460034,1.2366134390013033,0.3063945894067272,0.571973024948003,0.9897340531605416,Upregulated
Feature0569,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,3409825.7365343566,3147444.8283955697,0.9230515198100819,-0.11551692123061895,0.7715399575903832,0.9897340531605416,Downregulated
Feature0568,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Phenol,6071963.725215826,6483111.739217823,1.0677125280400754,0.09452326669053195,0.7658387373682314,0.9897340531605416,Upregulated
Feature0567,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,85967.6933367814,62700.7850996609,0.729352884391447,-0.4553110891402302,0.2833292270739838,0.9897340531605416,Downregulated
Feature0566,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0566,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Phenol,12638724.701915566,12345817.573777633,0.9768246294585767,-0.03382851828257619,0.7479458925600027,0.9897340531605416,Downregulated
Feature0565,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0565,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,60104.25716381443,56141.2935814647,0.9340651765889285,-0.09840487400919917,0.6663188225683218,0.9897340531605416,Downregulated
Feature0564,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,74664.1303626766,106841.6796116676,1.430963959436619,0.5169873364972568,0.5646269685012966,0.9897340531605416,Upregulated
Feature0563,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6299208.390535846,4563672.1854009135,0.7244834433890989,-0.46497537461982125,0.3222856993270587,0.9897340531605416,Downregulated
Feature0562,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Phenol,1642713.2628817733,2489346.74676544,1.5153872577849876,0.5996865220761279,0.1784323452279241,0.9897340531605416,Upregulated
Feature0561,NA,C11 H23 N O11,345.1272,NA,NA,Feature0561,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,12875932.517771,12239671.444943676,0.9505852432863271,-0.07311208921059083,0.8809684639043688,0.9897340531605416,Downregulated
Feature0560,NA,C10 H15 N O5,229.09493,NA,NA,Feature0560,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,2287781.829205407,1915775.0001304466,0.837394097493918,-0.25602134583979536,0.3200337357447685,0.9897340531605416,Downregulated
Feature0559,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0559,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,6551432.641093473,6547548.561138077,0.999407140366363,-8.555692947078581e-4,0.9968223609722289,0.9990212121416295,Downregulated
Feature0558,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,1350247.6732824459,1017958.0987095187,0.7539047234459344,-0.40754588398931707,0.24123155021562936,0.9897340531605416,Downregulated
Feature0557,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Phenol,204858.878200138,195661.323218694,0.9551029710684132,-0.06627181426101399,0.8455937081781879,0.9897340531605416,Downregulated
Feature0556,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,3321441.81111139,3041509.6629547235,0.9157196891963619,-0.1270220521283205,0.2335754011816744,0.9897340531605416,Downregulated
Feature0555,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8608319.112382207,7921052.253901347,0.9201624789336288,-0.12003946539688377,0.7396466925840776,0.9897340531605416,Downregulated
Feature0554,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,10399558.715550587,9532137.68396534,0.916590592417332,-0.12565061644386066,0.4174362335531096,0.9897340531605416,Downregulated
Feature0553,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Phenol,11936949.591030186,11877829.478823144,0.9950473015106417,-0.007162986283534486,0.9818327322702562,0.9990212121416295,Downregulated
Feature0552,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,1121523.938771032,1557010.30003936,1.3882987658253063,0.4733180733859209,0.40803691477991055,0.9897340531605416,Upregulated
Feature0551,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Phenol,2400472.907975043,3707453.9976610467,1.5444681693110747,0.6271101380744717,0.11466091176865315,0.9897340531605416,Upregulated
Feature0550,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,692644.1305706113,580869.6551406297,0.8386264020776442,-0.2538998443037118,0.19948859755356702,0.9897340531605416,Downregulated
Feature0549,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,4940632.233523197,4766597.710363567,0.9647748476442407,-0.0517357992288967,0.887639235160026,0.9897340531605416,Downregulated
Feature0548,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0548,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,6421170.601666204,4592602.355515569,0.7152282099970765,-0.48352445453466836,0.06218909699168292,0.9897340531605416,Downregulated
Feature0547,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0547,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,6557086.26726705,4920355.111841793,0.7503874299174905,-0.41429243407510596,0.2665984165082621,0.9897340531605416,Downregulated
Feature0546,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,10855419.90333594,12410538.034044873,1.143257298617351,0.19315012941861068,0.5186972086601138,0.9897340531605416,Upregulated
Feature0545,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0545,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,298609.0422806,264645.8106074333,0.8862618780269494,-0.17419503684466883,0.6067920532452069,0.9897340531605416,Downregulated
Feature0544,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,270219.7573410037,406493.2556241737,1.5043061973858547,0.5890982535106386,0.5541589204626807,0.9897340531605416,Upregulated
Feature0543,NA,C11 H19 N O5,245.12631,NA,NA,Feature0543,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,224059.26639596434,264504.8653835423,1.180512949266295,0.23941386684381444,0.4821349300547629,0.9897340531605416,Upregulated
Feature0542,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,2435858.590103703,3196285.065160737,1.3121800576381817,0.3919657004728674,0.48077559201382414,0.9897340531605416,Upregulated
Feature0541,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0541,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,272754.69049202633,385865.77157241065,1.414698940195461,0.5004950681108169,0.12955978739281043,0.9897340531605416,Upregulated
Feature0540,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0540,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,5094754.515995524,5188070.20932826,1.018316033292627,0.02618536976971334,0.9006249351800741,0.9897340531605416,Upregulated
Feature0539,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Phenol,1391211.2736032533,2350727.494670027,1.689698422714485,0.7567657773483843,0.42898662493864376,0.9897340531605416,Upregulated
Feature0538,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,213899.92014167886,350292.2304917703,1.637645447739067,0.7116230455284044,0.28680326734784456,0.9897340531605416,Upregulated
Feature0537,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Phenol,1244050.0402509067,811907.734213956,0.6526326979983909,-0.6156568241931409,0.0869932942319117,0.9897340531605416,Downregulated
Feature0536,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0536,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,5252073.050894183,5568102.498866077,1.0601723252722253,0.08429878611793744,0.8254479334729595,0.9897340531605416,Upregulated
Feature0535,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,3553721.9928248003,4270972.803464863,1.2018308725579097,0.2652338873223447,0.3898918331011289,0.9897340531605416,Upregulated
Feature0534,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0534,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,11782817.919997633,10709495.0512185,0.9089077947171276,-0.13779414903950207,0.5296666228377374,0.9897340531605416,Downregulated
Feature0533,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,159844.72874109924,113398.65837815574,0.7094300779966771,-0.4952675967868719,0.6336873877147671,0.9897340531605416,Downregulated
Feature0532,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0532,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,545815.3889943734,2166897.9702295805,3.9700199260082027,1.9891462484465898,0.4479601004395537,0.9897340531605416,Upregulated
Feature0531,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,6366127.266636596,5557066.814436113,0.8729116748198577,-0.19609241210475045,0.5130694207533477,0.9897340531605416,Downregulated
Feature0530,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,263259.091321997,356357.972770707,1.353639758388587,0.4368438482658887,0.4934958401848652,0.9897340531605416,Upregulated
Feature0529,NA,C12 H19 N O9,321.10608,NA,NA,Feature0529,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,525756.540125486,564683.7978674037,1.0740404631630958,0.10304834612137097,0.7120567448390245,0.9897340531605416,Upregulated
Feature0528,NA,C6 H15 N O4,165.10013,NA,NA,Feature0528,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,7912218.18631192,9610408.353845356,1.2146288344868057,0.28051552333515883,0.2209921894241198,0.9897340531605416,Upregulated
Feature0527,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1774399.88387588,2137530.057660097,1.2046495703048739,0.268613530928454,0.6080341626264617,0.9897340531605416,Upregulated
Feature0526,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0526,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,5608325.273773484,5820202.25849111,1.0377790114472207,0.05349926351077968,0.8595163858072095,0.9897340531605416,Upregulated
Feature0525,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Phenol,4143905.338695553,3664469.3063085866,0.8843033338840972,-0.177386766870445,0.759820912096137,0.9897340531605416,Downregulated
Feature0524,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0524,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,9651708.019158121,6233983.499703887,0.6458943315866751,-0.6306299357969596,0.509129116674549,0.9897340531605416,Downregulated
Feature0523,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0523,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,9083533.39245301,8670450.868236627,0.9545240264587359,-0.06714658252099595,0.6129238647120356,0.9897340531605416,Downregulated
Feature0522,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0522,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Phenol,74845.23976891796,67961.7539991245,0.9080304132761685,-0.1391874754021248,0.616277042444707,0.9897340531605416,Downregulated
Feature0521,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,260028.60555370332,393743.2879549537,1.5142306636476364,0.5985849886480767,0.41280169311885584,0.9897340531605416,Upregulated
Feature0520,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,8493476.626694597,10216090.839905549,1.2028161480773205,0.266416141659977,0.7024524664018958,0.9897340531605416,Upregulated
Feature0519,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,10910470.869058633,11222253.74310179,1.0285764819671857,0.04064907247479377,0.7752230122579971,0.9897340531605416,Upregulated
Feature0518,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,2920989.41032695,2598686.3924505324,0.8896596417854382,-0.16867458692504278,0.8443131538920841,0.9897340531605416,Downregulated
Feature0517,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,494556.287955654,398610.82412336266,0.8059968780724619,-0.31115384422109243,0.3404103809310036,0.9897340531605416,Downregulated
Feature0516,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0516,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,5507846.8048586035,5515041.02427574,1.0013061763828996,0.001883184572095792,0.9966959410609388,0.9990212121416295,Upregulated
Feature0515,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0515,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2396837.5299947034,3908314.3978318702,1.6306129843688266,0.7054144081770315,0.2623067222055838,0.9897340531605416,Upregulated
Feature0514,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0514,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Phenol,1599886.56334768,1183012.4787820263,0.7394352236490028,-0.43550432567467146,0.41783993635622557,0.9897340531605416,Downregulated
Feature0513,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Phenol,1890101.3522957268,1917738.57386205,1.014622084436242,0.020942467868204324,0.9399511338338536,0.9897340531605416,Upregulated
Feature0512,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4909553.463811837,6004171.09422679,1.2229566575623108,0.2903732746519282,0.6326624264433155,0.9897340531605416,Upregulated
Feature0511,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,491404.36878685537,191237.86027480714,0.3891659749524038,-1.36154251506962,0.09647288590459577,0.9897340531605416,Downregulated
Feature0510,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,5645693.43595835,7605362.903074667,1.3471087279792522,0.429866298451292,0.5249256204038175,0.9897340531605416,Upregulated
Feature0509,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,175890.51113953366,192729.323434318,1.0957346259652754,0.13189843683723612,0.6789670362019994,0.9897340531605416,Upregulated
Feature0508,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1166934.8641069406,1312520.5361710996,1.124759038865101,0.1696159608475734,0.8475909691564478,0.9897340531605416,Upregulated
Feature0507,NA,C33 H47 N O8,585.33043,NA,NA,Feature0507,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Phenol,134558.62041443755,116955.95609343536,0.8691821879060118,-0.20226948512077886,0.5353668719848672,0.9897340531605416,Downregulated
Feature0506,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,4301509.4173783995,3359251.939041403,0.7809472473708391,-0.3567029966185555,0.5334232680794369,0.9897340531605416,Downregulated
Feature0505,NA,C29 H28 O9,520.17351,NA,NA,Feature0505,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Phenol,685363.4884107823,469497.9509920203,0.6850349616386627,-0.5457504751418052,0.487104472333039,0.9897340531605416,Downregulated
Feature0504,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Phenol,2698067.7333210767,3025859.86931744,1.121491440688511,0.16541860970339997,0.3453560268744349,0.9897340531605416,Upregulated
Feature0503,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Phenol,7861724.54903757,6750270.755345287,0.8586246838388217,-0.21990044674642495,0.2532198647173203,0.9897340531605416,Downregulated
Feature0502,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,201254.47446364065,177638.62604815734,0.8826567782981152,-0.18007554094027958,0.5468413302608733,0.9897340531605416,Downregulated
Feature0501,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Phenol,176842.277689002,153912.58340070868,0.870338164674525,-0.20035203449211877,0.510126530060266,0.9897340531605416,Downregulated
Feature0500,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,8463904.266064154,7306984.317334253,0.8633113144522975,-0.21204719848760256,0.18033813157662332,0.9897340531605416,Downregulated
Feature0499,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0499,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,39517.87566819543,45759.199561169466,1.1579367257840012,0.21155642095090713,0.5828323407396736,0.9897340531605416,Upregulated
Feature0498,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0498,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Phenol,162987.59735728067,141854.326397057,0.8703381649715469,-0.20035203399976748,0.5101265309426763,0.9897340531605416,Downregulated
Feature0497,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Phenol,1918994.4846711643,1956176.05597062,1.0193755488077012,0.027685653650278762,0.9605517030028132,0.9979064914529228,Upregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Phenol,303966.6820198697,504831.16207428934,1.6608108451875971,0.7318877697184014,0.2700024646999842,0.9897340531605416,Upregulated
Feature0495,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,10481416.981842566,8461443.392396813,0.8072804857449098,-0.3088580767903938,0.2612157867951999,0.9897340531605416,Downregulated
Feature0494,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,299601.74457640667,240544.923086796,0.8028822509925354,-0.3167396742249096,0.4852456318514817,0.9897340531605416,Downregulated
Feature0493,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Phenol,103927.76155816687,94937.26753701434,0.9134928542060374,-0.13053465146627305,0.6417760395618979,0.9897340531605416,Downregulated
Feature0492,NA,C10 H23 N O6,253.1525,NA,NA,Feature0492,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1961608.9376341186,1593701.7844983975,0.8124462291758056,-0.29965576182008474,0.845093058040965,0.9897340531605416,Downregulated
Feature0491,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,576611.8322363817,128567.8672562695,0.22297126085259236,-2.1650703241918827,0.43075191438058136,0.9897340531605416,Downregulated
Feature0490,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,4760617.04014335,4952372.7275492,1.0402795868243322,0.05697132097842335,0.9321513540720896,0.9897340531605416,Upregulated
Feature0489,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0489,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,8025297.662252317,6660624.79939619,0.8299536141475494,-0.2688973879571373,0.10403331187736013,0.9897340531605416,Downregulated
Feature0488,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0488,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,1587830.1192735333,2163035.25160993,1.3622586102596197,0.44600060960748256,0.40691523154510406,0.9897340531605416,Upregulated
Feature0487,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,176853.39313272532,227925.270719312,1.288780874836018,0.36600699010687177,0.4966178169109346,0.9897340531605416,Upregulated
Feature0486,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,1883606.5964518567,1632537.85026104,0.8667085013060827,-0.2063812391941319,0.32066118270337635,0.9897340531605416,Downregulated
Feature0485,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,145965.43419812666,134886.556261532,0.9240993047603537,-0.11388020126850387,0.5061819909702928,0.9897340531605416,Downregulated
Feature0484,NA,C18 H29 N O12,451.16881,NA,NA,Feature0484,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,146066.14499468467,127244.78203263487,0.8711449325732893,-0.1990153346047644,0.605166460858805,0.9897340531605416,Downregulated
Feature0483,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,419744.71935261664,729885.4435841826,1.738879394861487,0.7981578737203376,0.3487500280347666,0.9897340531605416,Upregulated
Feature0482,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0482,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,5084467.2575374795,4745148.476445164,0.9332636510562061,-0.09964338858156829,0.8482207009822129,0.9897340531605416,Downregulated
Feature0481,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Phenol,3277426.1950552133,4263146.707141563,1.3007605521593582,0.379355410936537,0.7132354967692368,0.9897340531605416,Upregulated
Feature0480,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,556837.9830681073,605605.7241150327,1.087579767418561,0.12112121782469012,0.8155041830431617,0.9897340531605416,Upregulated
Feature0479,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,10775765.884365793,10154069.592775337,0.9423060691683683,-0.08573235909216248,0.5940121610552191,0.9897340531605416,Downregulated
Feature0478,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0478,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,186637.47337132934,161932.18585864868,0.8676295437008642,-0.20484891575333186,0.32684066131429124,0.9897340531605416,Downregulated
Feature0477,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Phenol,4855506.10469708,5908462.847605454,1.2168582883439838,0.28316116590905077,0.5280669859326945,0.9897340531605416,Upregulated
Feature0476,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,1673299.7019721137,2087112.697202087,1.2473035731389077,0.31881263610678073,0.7367456507621039,0.9897340531605416,Upregulated
Feature0475,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2958369.28985073,2828100.97342946,0.9559661747205864,-0.0649685231522614,0.9029319824295692,0.9897340531605416,Downregulated
Feature0474,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0474,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,6650038.839824236,6782241.005542004,1.0198799088098651,0.02839928438846125,0.25229413338533807,0.9897340531605416,Upregulated
Feature0473,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Phenol,8026357.25866399,6599605.258966593,0.8222416528796672,-0.28236563750650784,0.5768739522484906,0.9897340531605416,Downregulated
Feature0472,NA,C19 H35 P S,326.21985,NA,NA,Feature0472,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,3204041.16929384,794759.6645957816,0.24804914250553903,-2.0113021249784593,0.18149262963389992,0.9897340531605416,Downregulated
Feature0471,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,5077344.46968108,7084693.9448800245,1.3953542028092947,0.4806313885583129,0.7010056722913915,0.9897340531605416,Upregulated
Feature0470,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,5643104.736007187,5850708.160659833,1.0367888661232854,0.05212213059311382,0.9326514582287777,0.9897340531605416,Upregulated
Feature0469,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,353214.8129669259,1443006.2576421888,4.08535034394865,2.0304598036596806,0.46934546155956886,0.9897340531605416,Upregulated
Feature0468,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,563677.1994604319,528440.5183948703,0.9374878368341115,-0.09312812210128667,0.7388144814077318,0.9897340531605416,Downregulated
Feature0467,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,9721686.267426167,9297438.488600686,0.9563606799113668,-0.06437327899822035,0.7526435602209389,0.9897340531605416,Downregulated
Feature0466,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,1253384.5784716664,1673793.954522882,1.3354192984916473,0.4172927942554817,0.6463554032821971,0.9897340531605416,Upregulated
Feature0465,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1673348.19833275,1493465.6244444633,0.8925014088116784,-0.16407364845260783,0.3060929104267913,0.9897340531605416,Downregulated
Feature0464,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0464,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,7479280.28526706,2062775.0800962267,0.27579860647281146,-1.858312927520035,0.24359938542366052,0.9897340531605416,Downregulated
Feature0463,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3122737.8249198734,2849477.657769507,0.9124934008325281,-0.13211396956418042,0.6803946636169447,0.9897340531605416,Downregulated
Feature0462,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0462,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,542839.7636084047,596102.8254112094,1.098119307710162,0.1350348077957639,0.7762579079105809,0.9897340531605416,Upregulated
Feature0461,NA,C29 H28 O9,520.17353,NA,NA,Feature0461,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Phenol,146689.72480960272,124246.96127210543,0.8470052107151534,-0.2395572499464317,0.4976005940498706,0.9897340531605416,Downregulated
Feature0460,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,108768.4869734146,146221.54799001606,1.3443374276756814,0.42689529893168787,0.5438547140811187,0.9897340531605416,Upregulated
Feature0459,NA,C14 H29 N O2,243.2198,NA,NA,Feature0459,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,1650489.6858632895,2142838.205476678,1.2983045115824916,0.3766288007684494,0.7620153127399409,0.9897340531605416,Upregulated
Feature0458,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0458,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,278476.916701044,239744.99444585168,0.8609151425761705,-0.21605705171096626,0.45102857909284133,0.9897340531605416,Downregulated
Feature0457,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,5231804.973110854,4794569.70263447,0.916427452337467,-0.12590741848188353,0.6484806787212593,0.9897340531605416,Downregulated
Feature0456,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,9708852.2645758,8420861.01273459,0.8673384642445701,-0.20533300409400115,0.4662624569377519,0.9897340531605416,Downregulated
Feature0455,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0455,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Phenol,9818673.753141271,9325267.845270773,0.9497482124087642,-0.07438300339736797,0.6767836807291057,0.9897340531605416,Downregulated
Feature0454,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3285217.60382081,2707313.0994711802,0.824089429060191,-0.2791271896864897,0.5175895887344499,0.9897340531605416,Downregulated
Feature0453,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,8470480.94020404,7120508.705444187,0.840626259088503,-0.2504635714630756,0.3532380507623413,0.9897340531605416,Downregulated
Feature0452,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,115893.39039873297,104385.47420811733,0.9007025668071106,-0.15087732207266757,0.5118963498343322,0.9897340531605416,Downregulated
Feature0451,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,3768027.0972151533,3322502.5030065468,0.8817618390966769,-0.18153905356228947,0.41275182381956566,0.9897340531605416,Downregulated
Feature0450,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,377961.23666151334,2894722.7969191205,7.658782213985388,2.9371150144068445,0.4346395743920418,0.9897340531605416,Upregulated
Feature0449,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,6928330.7856964795,6514628.680821776,0.9402883439502066,-0.08882486086572793,0.8068781673211207,0.9897340531605416,Downregulated
Feature0448,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Phenol,3433886.742378313,3537491.0106457234,1.0301711372681015,0.042884025154917155,0.9251855834587424,0.9897340531605416,Upregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1518090.7244955266,2528662.771620593,1.6656862009751672,0.7361166366350629,0.5455522516869309,0.9897340531605416,Upregulated
Feature0446,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0446,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,5652638.399947284,5787129.597014196,1.0237926411617213,0.0339235416454419,0.9797821115329512,0.9990212121416295,Upregulated
Feature0445,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0445,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Phenol,6321186.46198739,3960882.24801656,0.6266042414403408,-0.6743735596433877,0.3366409710792129,0.9897340531605416,Downregulated
Feature0444,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Phenol,102201.06187416603,89592.91753513219,0.8766339203543944,-0.189953591497893,0.5156464040115702,0.9897340531605416,Downregulated
Feature0443,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0443,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2012029.1801506067,1761892.0028046733,0.8756791502759369,-0.19152573316227472,0.6558836068004286,0.9897340531605416,Downregulated
Feature0442,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,153157.48429534296,356446.6632251597,2.3273212201488094,1.2186703472852134,0.11090495075748577,0.9897340531605416,Upregulated
Feature0441,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,2166961.8628233066,2056059.2447472697,0.9488211491034072,-0.07579192715505699,0.8911223579229739,0.9897340531605416,Downregulated
Feature0440,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,318839.25969845965,867720.5985131452,2.721498598804259,1.4444012932745933,0.4873906869407882,0.9897340531605416,Upregulated
Feature0439,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1824762.04941803,2297446.561210343,1.2590389864492557,0.3323229571523746,0.41901920628880496,0.9897340531605416,Upregulated
Feature0438,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3490583.17412986,3481649.63055376,0.9974406730536289,-0.0036970613084710688,0.9958928434855625,0.9990212121416295,Downregulated
Feature0437,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Phenol,442874.555185057,476358.49444124964,1.075605922408889,0.10514960398873735,0.8751902834098946,0.9897340531605416,Upregulated
Feature0436,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,5748634.18869586,5593559.785855964,0.9730241309936132,-0.039452510607466226,0.8676129189433335,0.9897340531605416,Downregulated
Feature0435,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,561369.1894856766,461291.3130609667,0.8217253844722032,-0.2832717601705004,0.5195854694994881,0.9897340531605416,Downregulated
Feature0434,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0434,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,285437.2866776957,300714.21364673466,1.0535211329495613,0.07521925397082482,0.8836138620131901,0.9897340531605416,Upregulated
Feature0433,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0433,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,270951.36733339867,348958.91763303865,1.2879024050233108,0.36502327270444723,0.6035530155766176,0.9897340531605416,Upregulated
Feature0432,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0432,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Phenol,5025577.483352207,6787742.424846357,1.3506392941570438,0.4336424355718577,0.471747066593361,0.9897340531605416,Upregulated
Feature0431,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0431,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,127609.83589699194,119188.22808971413,0.9340050259599438,-0.09849778166765241,0.7433738397203113,0.9897340531605416,Downregulated
Feature0430,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,145270.3541977877,207447.58088437235,1.4280104294502474,0.5140065161045512,0.11329350868800396,0.9897340531605416,Upregulated
Feature0429,NA,C7 H15 N O6,209.08992,NA,NA,Feature0429,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2144145.924749793,2011755.8408600134,0.9382550961846364,-0.09194787367563295,0.8851544755442158,0.9897340531605416,Downregulated
Feature0428,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0428,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,63121.0101593427,62086.83184302327,0.9836159416063089,-0.023832977795994487,0.9289633611595913,0.9897340531605416,Downregulated
Feature0427,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,6459122.87642545,8466754.954564746,1.3108211620290993,0.3904708691956241,0.4040757249172821,0.9897340531605416,Upregulated
Feature0426,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Phenol,1088685.1367457933,778762.650589169,0.7153240402610632,-0.48333116715659097,0.5421665986904702,0.9897340531605416,Downregulated
Feature0425,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0425,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,91858.44420093454,76287.6576065924,0.8304915053831956,-0.267962683116584,0.40166627427730867,0.9897340531605416,Downregulated
Feature0424,NA,C16 H25 N O9,375.15307,NA,NA,Feature0424,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,255665.52351066965,304931.870063072,1.1926984361281951,0.2542293157079327,0.3185216311073812,0.9897340531605416,Upregulated
Feature0423,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Phenol,819473.6828158466,963773.0735599953,1.1760878888121362,0.23399587651403292,0.57357481108553,0.9897340531605416,Upregulated
Feature0422,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Phenol,723229.609393311,628076.1049798554,0.8684325099835498,-0.2035143602814469,0.5206570095090512,0.9897340531605416,Downregulated
Feature0421,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0421,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,127278.45703487027,547719.2450589485,4.303314620705143,2.10544832137802,0.46707351949047543,0.9897340531605416,Upregulated
Feature0420,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0420,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2477718.843356143,3278427.06832068,1.3231634723655545,0.4039913127139772,0.2368553319071444,0.9897340531605416,Upregulated
Feature0419,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,817420.4554110516,981932.2823998576,1.2012572916420092,0.26454518819681094,0.6657174492933555,0.9897340531605416,Upregulated
Feature0418,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0418,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,170497.970211232,145345.582952583,0.8524769108542032,-0.23026733529276966,0.4103951075885776,0.9897340531605416,Downregulated
Feature0417,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0417,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5996040.11259655,6098503.23612538,1.0170884653212333,0.024445168801681717,0.9624361507098046,0.9980160453756015,Upregulated
Feature0416,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,110860.1679948662,296265.84435313987,2.672428246427153,1.4181512127115603,0.487830971428304,0.9897340531605416,Upregulated
Feature0415,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1724936.0307892533,1566827.4806715974,0.9083394703945558,-0.1386965234430992,0.8667273725386928,0.9897340531605416,Downregulated
Feature0414,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,999870.8205950904,1439732.6925151767,1.439918700356007,0.5259873575673512,0.29487027280923284,0.9897340531605416,Upregulated
Feature0413,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0413,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,104909.29108748354,162181.3349750367,1.5459196539589062,0.6284653400601677,0.5927149169841804,0.9897340531605416,Upregulated
Feature0412,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0412,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,104766.02819529513,61817.000600415966,0.5900481450454763,-0.7610954187441834,0.1973048895148511,0.9897340531605416,Downregulated
Feature0411,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,787988.3219784843,704476.1647109044,0.8940185343636854,-0.1616233539067352,0.8459480772201059,0.9897340531605416,Downregulated
Feature0410,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0410,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,4099839.73693005,4156640.8628649036,1.0138544747062201,0.0198505875615671,0.9819749375394399,0.9990212121416295,Upregulated
Feature0409,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,589143.1331430944,523421.01822871855,0.8884445710777505,-0.17064632372707203,0.8204167077855087,0.9897340531605416,Downregulated
Feature0408,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0408,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,2941129.3677087394,204119.90407128166,0.06940187885387016,-3.848881469673354,0.4146328131511737,0.9897340531605416,Downregulated
Feature0407,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0407,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,785469.737303838,731741.3491812017,0.9315971251711599,-0.10222190736489331,0.813538565089594,0.9897340531605416,Downregulated
Feature0406,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,4705980.250155074,6823822.949440382,1.4500322115069482,0.536084949112737,0.5660734210216292,0.9897340531605416,Upregulated
Feature0405,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0405,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,1099504.32948552,1403762.0417993267,1.276722614140296,0.35244511339321233,0.40082622064833423,0.9897340531605416,Upregulated
Feature0404,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1013431.1569293056,917564.5397934524,0.9054039176905425,-0.1433665457342483,0.6626312987413289,0.9897340531605416,Downregulated
Feature0403,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Phenol,144410.36833003056,162747.89277343865,1.1269820488339184,0.17246453568356618,0.6551506486062262,0.9897340531605416,Upregulated
Feature0402,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,1506497.2563150222,462258.52573444135,0.30684325762739983,-1.7044262118987656,0.2332886709572054,0.9897340531605416,Downregulated
Feature0401,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0401,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,4794005.392953407,3349777.9678507335,0.6987430537259076,-0.5171660588349295,0.5294216632593235,0.9897340531605416,Downregulated
Feature0400,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0400,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,4531041.54984468,2312199.3839142574,0.5103019600412884,-0.9705769118433012,0.4402075179091947,0.9897340531605416,Downregulated
Feature0399,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,6507683.52688069,6294084.404901774,0.9671773955975852,-0.04814756787719765,0.855997608627029,0.9897340531605416,Downregulated
Feature0398,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,5884337.157569326,5718736.278833443,0.9718573436053265,-0.04118353494266318,0.9165110464426127,0.9897340531605416,Downregulated
Feature0397,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0397,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,6878915.081698104,6463433.149547707,0.939600659811048,-0.08988036844041063,0.7850352617451161,0.9897340531605416,Downregulated
Feature0396,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,4391870.857388597,4269220.044683304,0.9720732196624239,-0.04086310856099468,0.9618603181622454,0.9980160453756015,Downregulated
Feature0395,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0395,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1804279.41989807,2132689.972493423,1.182017568328694,0.2412514784531152,0.47492687979337056,0.9897340531605416,Upregulated
Feature0394,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0394,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Phenol,75397.8563274629,66197.6369466956,0.8779777061457884,-0.18774378797554298,0.4728052751185954,0.9897340531605416,Downregulated
Feature0393,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0393,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8642697.781166019,7876864.787347584,0.9113895900088834,-0.13386020285191794,0.5376820395763046,0.9897340531605416,Downregulated
Feature0392,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2114476.902739187,2459794.1533129266,1.163310958907331,0.21823678804856525,0.5598731625482765,0.9897340531605416,Upregulated
Feature0391,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0391,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,4775681.652696704,4920355.111841793,1.0302937820537925,0.04305577185407912,0.8883732295745683,0.9897340531605416,Upregulated
Feature0390,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,1724426.7963486498,1251538.0618939367,0.7257704789463831,-0.46241471917210575,0.4524567847983112,0.9897340531605416,Downregulated
Feature0389,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,1764659.1056601333,2626625.9952857336,1.488460851651657,0.5738212774236199,0.35979761115391007,0.9897340531605416,Upregulated
Feature0388,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0388,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,892035.3231210996,1196818.0232165132,1.3416711112167892,0.42403106172582516,0.019251826279691412,0.9897340531605416,Upregulated
Feature0387,NA,C10 H21 N O10,315.11663,NA,NA,Feature0387,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,4407883.5256380765,3651071.3321079835,0.8283048567122612,-0.2717662470658278,0.6790703108604277,0.9897340531605416,Downregulated
Feature0386,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0386,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Phenol,3745050.84004458,3467661.2139541768,0.9259316794516196,-0.11102234778697125,0.8086019347608133,0.9897340531605416,Downregulated
Feature0385,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0385,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,1280997.4780926933,975346.6895269883,0.7613962604978775,-0.39328061058531694,0.6501578959074806,0.9897340531605416,Downregulated
Feature0384,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Phenol,1257826.8265141067,1546036.7005971817,1.229133190680794,0.2976412567384658,0.6080255230508218,0.9897340531605416,Upregulated
Feature0383,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,5987453.581593187,4495230.612443507,0.7507750250061032,-0.4135474360599926,0.33841416333685836,0.9897340531605416,Downregulated
Feature0382,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,191134.16094799433,188933.71067478,0.9884874045419174,-0.016705511857193125,0.9769163265536598,0.9990212121416295,Downregulated
Feature0381,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,6880024.239859833,3867338.7625207696,0.562111211776713,-0.831072503932281,0.001062688650243463,0.9897340531605416,Downregulated
Feature0380,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Phenol,8429388.42041347,6912298.66627033,0.8200237456765902,-0.28626240799341157,0.08146035190945006,0.9897340531605416,Downregulated
Feature0379,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Phenol,5208828.83693448,3642194.4459171966,0.6992348107296832,-0.5161510850818112,0.16030531647466836,0.9897340531605416,Downregulated
Feature0378,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Phenol,3414505.0617016465,3402162.40285457,0.9963852275442446,-0.005224462616768915,0.9759084089879095,0.9990212121416295,Downregulated
Feature0377,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1752501.177375543,521261.22982417064,0.2974384477189254,-1.7493369486796893,0.2889215689557904,0.9897340531605416,Downregulated
Feature0376,NA,C13 H17 N O5,267.11069,NA,NA,Feature0376,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Phenol,4699759.4460987765,4386988.7627937365,0.9334496399460045,-0.09935590442301669,0.7828154986233682,0.9897340531605416,Downregulated
Feature0375,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0375,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Phenol,231355.63272933065,169863.765211783,0.7342106315194465,-0.4457340897806932,0.24769607355206233,0.9897340531605416,Downregulated
Feature0374,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Phenol,4076380.96721636,3833745.65185232,0.9404777626734607,-0.08853426284542985,0.8754395932645873,0.9897340531605416,Downregulated
Feature0373,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Phenol,370896.324264279,85905.84797181617,0.2316168760696714,-2.110187720079139,0.16313429395123819,0.9897340531605416,Downregulated
Feature0372,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0372,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,532735.3405007087,1033861.4866724666,1.9406662334448437,0.9565520166816153,0.5833814719546349,0.9897340531605416,Upregulated
Feature0371,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,7266901.4185193395,6936678.46893246,0.9545579428468202,-0.0670953212282009,0.8461208137989649,0.9897340531605416,Downregulated
Feature0370,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,8884262.047400687,7887684.64911979,0.8878266542607812,-0.17165007309909044,0.6493864296732155,0.9897340531605416,Downregulated
Feature0369,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,634479.2366289264,2416318.735788417,3.8083495822915245,1.929165914961514,0.49642013719620576,0.9897340531605416,Upregulated
Feature0368,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1956645.5294857032,2291770.2705716966,1.1712751420918226,0.22808001649226034,0.25853584259908846,0.9897340531605416,Upregulated
Feature0367,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0367,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,2153138.435743601,3642623.2541826,1.691773828246485,0.7585367087194561,0.4596716835165012,0.9897340531605416,Upregulated
Feature0366,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,3879025.80406628,2512109.89762965,0.6476136082921314,-0.62679479360559,0.4853455176653927,0.9897340531605416,Downregulated
Feature0365,NA,C20 H31 N O14,509.17464,NA,NA,Feature0365,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,8254923.030264667,7493973.488755557,0.9078186993725715,-0.13952388947757086,0.765497251388899,0.9897340531605416,Downregulated
Feature0364,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0364,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,124412.82469717889,111058.38075375723,0.8926602303586756,-0.16381694222072823,0.6301679129158396,0.9897340531605416,Downregulated
Feature0363,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0363,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,4155614.12247135,4001255.4215834867,0.9628553815780986,-0.05460896966175635,0.9327987350617701,0.9897340531605416,Downregulated
Feature0362,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0362,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,82172.98055802593,105475.61207912528,1.2835802153317823,0.36017345769379466,0.6080528449416951,0.9897340531605416,Upregulated
Feature0361,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0361,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,842195.5622514903,1225453.8591368403,1.4550704302700948,0.5410889860835504,0.43701232059457884,0.9897340531605416,Upregulated
Feature0360,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Phenol,7396339.85572627,7191007.13351575,0.9722386036585987,-0.04061767604462833,0.9335784470690032,0.9897340531605416,Downregulated
Feature0359,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Phenol,1617090.2575549968,1479433.4915533802,0.9148737892900607,-0.12835536364845065,0.5324116120519522,0.9897340531605416,Downregulated
Feature0358,NA,C16 H33 N O2,271.25118,NA,NA,Feature0358,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,4564451.377474864,5130945.887590209,1.1241100985128119,0.16878334409944387,0.9033524767442989,0.9897340531605416,Upregulated
Feature0357,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0357,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,168210.779732954,138436.29636925668,0.8229930126299496,-0.2810479129487405,0.37001893108576794,0.9897340531605416,Downregulated
Feature0356,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,700644.3010114203,1269748.4719216034,1.81225833149381,0.857788621499291,0.0666163419948951,0.9897340531605416,Upregulated
Feature0355,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,1496492.7736539466,1406988.16819448,0.9401904192020082,-0.08897511573858484,0.5083256676479508,0.9897340531605416,Downregulated
Feature0354,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,259494.76766930366,2314388.64729457,8.918825871063394,3.1568537974227477,0.425624459577976,0.9897340531605416,Upregulated
Feature0353,NA,C25 H34 O2,366.25594,NA,NA,Feature0353,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,360201.44468169764,293457.08051637,0.8147026749870251,-0.2956544497578396,0.38032456135990417,0.9897340531605416,Downregulated
Feature0352,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3281134.0241894135,2735542.98931681,0.8337187597792842,-0.26236729670816306,0.2106887516602354,0.9897340531605416,Downregulated
Feature0351,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0351,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,5503148.91915246,5749686.33261862,1.0447993352693297,0.063225884114184,0.9168497205135999,0.9897340531605416,Upregulated
Feature0350,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,598049.0082573036,1596647.8404289212,2.6697608697345787,1.4167105256214272,0.3544283552912062,0.9897340531605416,Upregulated
Feature0349,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0349,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,86402.14918981993,76115.2188724584,0.8809412680839476,-0.1828822562961527,0.4913212796505613,0.9897340531605416,Downregulated
Feature0348,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0348,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,7428427.057799127,6202696.74860951,0.8349946361925007,-0.2601611648016714,0.23915173976441018,0.9897340531605416,Downregulated
Feature0347,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0347,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,4997622.914013526,5563753.742526763,1.1132800209727276,0.154816516361551,0.7795533677364183,0.9897340531605416,Upregulated
Feature0346,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0346,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1051301.5875547715,1322851.9449393933,1.2582991984404992,0.33147500710047173,0.6094014225563391,0.9897340531605416,Upregulated
Feature0345,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0345,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,105312.39300054264,312097.561568511,2.963540687627361,1.5673218649748215,0.18683378475262744,0.9897340531605416,Upregulated
Feature0344,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,357526.42592422635,256238.69529013,0.7166986178091264,-0.48056152268233043,0.49431390061831004,0.9897340531605416,Downregulated
Feature0343,NA,C6 H9 O P S,160.01125,NA,NA,Feature0343,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,2508435.6796545857,492905.63653077063,0.19649921284752428,-2.3474045616566497,0.2929669470545807,0.9897340531605416,Downregulated
Feature0342,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,193731.37647997434,257102.81771583235,1.3271098486331594,0.408287791596793,0.3361288410683157,0.9897340531605416,Upregulated
Feature0341,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0341,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,82323.27072426496,80344.79550694377,0.975966999368284,-0.03509572850559011,0.9178007417819576,0.9897340531605416,Downregulated
Feature0340,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Phenol,157305.62647279262,1974875.557932982,12.554386020480672,3.65011956938548,0.41340088243440926,0.9897340531605416,Upregulated
Feature0339,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3943388.5065538534,3651874.0417380133,0.9260751345368716,-0.11079884759363055,0.825994284306724,0.9897340531605416,Downregulated
Feature0338,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1079335.712286582,1037988.1072628137,0.9616916177672162,-0.05635375062469185,0.9408819507665864,0.9897340531605416,Downregulated
Feature0337,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Phenol,177730.47773169866,152456.48854597867,0.8577959756352339,-0.22129354732693818,0.5117621470007506,0.9897340531605416,Downregulated
Feature0336,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,2997902.415036887,2927873.59650025,0.9766407278017503,-0.034100152492123365,0.9234529602647141,0.9897340531605416,Downregulated
Feature0335,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Phenol,737476.6437047997,888245.1291963467,1.2044383192044483,0.26836051324730215,0.8437452346787631,0.9897340531605416,Upregulated
Feature0334,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,3972947.1803183733,2486817.3320339834,0.6259376777907986,-0.6759090741801027,0.06846840308167702,0.9897340531605416,Downregulated
Feature0333,NA,C28 H40,376.313,NA,NA,Feature0333,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,750043.8661213659,1577856.07829384,2.1036850637193587,1.072918739317106,0.22895047278572267,0.9897340531605416,Upregulated
Feature0332,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0332,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1033142.634640396,1209976.2690568455,1.1711609108823582,0.22793930759279607,0.6299330794748201,0.9897340531605416,Upregulated
Feature0331,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,6159828.726237137,4459995.629154887,0.7240453959633665,-0.4658479411174624,0.5071524414191879,0.9897340531605416,Downregulated
Feature0330,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,93634.33271700867,56711.51670383217,0.605670111146427,-0.7233958764384975,0.014578909530800235,0.9897340531605416,Downregulated
Feature0329,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1865481.5234918934,1856851.0192489838,0.9953735782776585,-0.006690003023834468,0.9916252666034282,0.9990212121416295,Downregulated
Feature0328,NA,C11 H21 N O12,359.10644,NA,NA,Feature0328,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,2095120.9533763267,2802096.231372941,1.3374388847848189,0.41947296805035034,0.6572120883976982,0.9897340531605416,Upregulated
Feature0327,NA,C17 H33 N O15,491.18523,NA,NA,Feature0327,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,6416242.20511605,6154113.73300531,0.9591461070622102,-0.06017749666316969,0.666162173829978,0.9897340531605416,Downregulated
Feature0326,NA,C8 H19 N O4,193.13145,NA,NA,Feature0326,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,1836574.5667863253,551029.9491727434,0.30003135137439396,-1.7368148338024325,0.279010664662808,0.9897340531605416,Downregulated
Feature0325,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0325,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,673439.3571701413,623849.218969059,0.9263628748853274,-0.11035065815354349,0.8699004524140066,0.9897340531605416,Downregulated
Feature0324,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,3356690.1597186686,2057504.9754436866,0.6129564772269986,-0.7061434554214145,0.629699883076944,0.9897340531605416,Downregulated
Feature0323,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0323,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,655966.844450812,753529.9218750291,1.1487317205885594,0.20004190453841755,0.871363934050862,0.9897340531605416,Upregulated
Feature0322,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0322,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Phenol,6446528.46764552,6961005.95804297,1.0798069058377018,0.11077334859544223,0.6227084628954083,0.9897340531605416,Upregulated
Feature0321,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2264493.17554906,2030891.534886699,0.8968415347042409,-0.1570750008159964,0.7611870316858901,0.9897340531605416,Downregulated
Feature0320,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,1960888.7651494402,1798024.6516856586,0.916943726559946,-0.12509489749456784,0.8444259671076018,0.9897340531605416,Downregulated
Feature0319,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Phenol,6213067.645839304,6298227.441208586,1.013706561753969,0.01964009497541322,0.88050551871906,0.9897340531605416,Upregulated
Feature0318,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Phenol,123615.33629907084,174218.6258745967,1.4093609344159204,0.4950411301775735,0.44533578371602417,0.9897340531605416,Upregulated
Feature0317,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,202637.611008148,237014.39685234468,1.1696466202555773,0.22607272108073578,0.5700009721191902,0.9897340531605416,Upregulated
Feature0316,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0316,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,565664.512093837,1341350.5200604415,2.3712827857900467,1.2456677207404818,0.1821076535925801,0.9897340531605416,Upregulated
Feature0315,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0315,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,526253.2525124854,706165.552969177,1.341873992412851,0.4242492027927369,0.403339415949951,0.9897340531605416,Upregulated
Feature0314,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,1025352.264860328,1379402.7619327216,1.3452964500162505,0.42792412061998586,0.45595125610906284,0.9897340531605416,Upregulated
Feature0313,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,528397.4591517963,371012.53812994965,0.7021467111623002,-0.5101555866481371,0.39287742325147346,0.9897340531605416,Downregulated
Feature0312,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0312,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,774806.8515744103,764397.5662261794,0.9865653158240931,-0.019513526760471033,0.9855441883327023,0.9990212121416295,Downregulated
Feature0311,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0311,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,2012152.2850399048,1121692.0731089127,0.557458837210558,-0.8430628145981902,0.597722609502755,0.9897340531605416,Downregulated
Feature0310,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,250850.70003442367,250962.621327745,1.000446166956305,6.435393029567716e-4,0.9832057172726557,0.9990212121416295,Upregulated
Feature0309,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Phenol,250726.23422737568,917843.358546872,3.6607392177178752,1.8721350031683552,0.4080159657202456,0.9897340531605416,Upregulated
Feature0308,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Phenol,170268.11029108067,146137.577903575,0.8582792024516307,-0.22048105500845652,0.5131344104206287,0.9897340531605416,Downregulated
Feature0307,NA,C7 H16 O6,196.09463,NA,NA,Feature0307,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,422190.27220287966,800244.9328703713,1.8954603778407781,0.9225482991410705,0.3859442066267677,0.9897340531605416,Upregulated
Feature0306,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,76161.32733040793,65337.5555896869,0.8578836251925513,-0.22114614033821256,0.4392927497772462,0.9897340531605416,Downregulated
Feature0305,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,1789893.9399690933,1267929.4208999036,0.7083824312639426,-0.49739966292555854,0.2565200564311731,0.9897340531605416,Downregulated
Feature0304,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0304,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,395909.7765801,217990.98319072655,0.5506077295533086,-0.8609032319390799,0.27052224436299943,0.9897340531605416,Downregulated
Feature0303,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,3332154.95319974,643570.7721144384,0.19313950916251424,-2.3722847786442443,0.035867678617459535,0.9897340531605416,Downregulated
Feature0302,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0302,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6291209.6227821,5601938.521057064,0.8904390183997356,-0.1674112829594508,0.2216370490113145,0.9897340531605416,Downregulated
Feature0301,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0301,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,105292.71798693883,88248.0470639132,0.8381210852099006,-0.25476940655654795,0.5503634186745584,0.9897340531605416,Downregulated
Feature0300,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,1589713.10991937,1456454.28573521,0.9161742937435303,-0.12630601097600855,0.49577027686850594,0.9897340531605416,Downregulated
Feature0299,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,814728.761896786,962121.7277150056,1.180910473167869,0.23989959571514247,0.7035999474085313,0.9897340531605416,Upregulated
Feature0298,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0298,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Phenol,7050414.138926746,6644688.921935529,0.9424537042794229,-0.08550634361155249,0.7501573544096862,0.9897340531605416,Downregulated
Feature0297,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Phenol,826836.8628371593,1359229.0691253152,1.6438902644728932,0.7171139972040907,0.3533745526549162,0.9897340531605416,Upregulated
Feature0296,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Phenol,568339.3433536077,613658.1127426433,1.0797389269615272,0.11068252136122922,0.8327781697130332,0.9897340531605416,Upregulated
Feature0295,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Phenol,102953.2381940693,89850.5197277297,0.8727313613813616,-0.19639045391404855,0.5527528777461203,0.9897340531605416,Downregulated
Feature0294,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,5286325.068503137,5472603.805417587,1.035237851342955,0.049962272584524896,0.8701742883840432,0.9897340531605416,Upregulated
Feature0293,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Phenol,487573.3534719033,382174.2501630487,0.7838292380862681,-0.35138870610731515,0.5322541713684572,0.9897340531605416,Downregulated
Feature0292,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,3053319.7334756833,2851656.921690769,0.9339529334009984,-0.09857824780030885,0.8551366787371963,0.9897340531605416,Downregulated
Feature0291,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0291,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,171362.771979607,154248.76088817566,0.9001299354945776,-0.15179482259716068,0.6106261498318226,0.9897340531605416,Downregulated
Feature0290,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Phenol,4556931.751015847,4030904.463195827,0.8845654671692733,-0.17695917337892242,0.8195106732324045,0.9897340531605416,Downregulated
Feature0289,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Phenol,1619609.30764591,1476396.0512867698,0.9115754301466077,-0.13356605497408444,0.8721170952625099,0.9897340531605416,Downregulated
Feature0288,NA,C8 H19 N O7,241.11608,NA,NA,Feature0288,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,510540.3849592857,508108.051061579,0.9952357659269195,-0.006889762153751978,0.9915251275843046,0.9990212121416295,Downregulated
Feature0287,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,644975.5384150697,1384064.3806329973,2.14591763283632,1.101594701919647,0.30794430914243043,0.9897340531605416,Upregulated
Feature0286,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0286,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,2663727.3992910935,2355821.984730717,0.8844080611843688,-0.1772159198262689,0.6104239749839746,0.9897340531605416,Downregulated
Feature0285,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,237094.83120873355,404524.4471653654,1.706171514170337,0.7707626819465854,0.6768952105823176,0.9897340531605416,Upregulated
Feature0284,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Phenol,3693112.9977902602,3756393.1896052165,1.017134648155315,0.02451067562369532,0.868676849236599,0.9897340531605416,Upregulated
Feature0283,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Phenol,2836920.12565454,2480454.2288962565,0.8743475737879511,-0.19372119582590122,0.7736891962772272,0.9897340531605416,Downregulated
Feature0282,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Phenol,7172753.99677277,6660824.80259233,0.9286286418841673,-0.1068263159567276,0.6398757983761443,0.9897340531605416,Downregulated
Feature0281,NA,C31 H37 N O11,599.23689,NA,NA,Feature0281,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Phenol,168866.77259980867,144934.83888145332,0.8582792022971223,-0.22048105526817213,0.5131344099016625,0.9897340531605416,Downregulated
Feature0280,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0280,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,124672.37834995372,281412.473897211,2.257215893542112,1.1745444130564386,0.4296991032621192,0.9897340531605416,Upregulated
Feature0279,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0279,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,971773.7872852724,1385032.3633747753,1.4252621150072113,0.5112272647135911,0.30560027180794413,0.9897340531605416,Upregulated
Feature0278,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,542006.2333020524,678386.9412432536,1.2516220286071844,0.32379895541620185,0.6257751305809213,0.9897340531605416,Upregulated
Feature0277,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0277,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,1126087.5930729522,1222691.8784777697,1.0857875408618938,0.1187418345131861,0.7464570054625452,0.9897340531605416,Upregulated
Feature0276,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1265677.661432221,1148743.9675209713,0.9076117897356825,-0.1398527453716802,0.7634097408154592,0.9897340531605416,Downregulated
Feature0275,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,575281.0960507314,741657.010490743,1.2892080333982323,0.3664850833547139,0.5892441954255679,0.9897340531605416,Upregulated
Feature0274,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,2658227.2584713465,3139057.670342167,1.1808838617309678,0.23986708468106754,0.691921847561845,0.9897340531605416,Upregulated
Feature0273,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0273,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Phenol,4124026.6026954,3721916.6651080665,0.9024957944440706,-0.14800788571173118,0.2582379061329249,0.9897340531605416,Downregulated
Feature0272,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Phenol,1227971.1473371033,1539345.7552617732,1.253568342057463,0.326040651185564,0.2426931893249162,0.9897340531605416,Upregulated
Feature0271,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,87072.6396807853,74841.34307237017,0.8595276696186545,-0.21838401169469185,0.4158579803520386,0.9897340531605416,Downregulated
Feature0270,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0270,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,199103.111052055,179201.79253884533,0.9000451655021778,-0.15193069521052377,0.7334070918813775,0.9897340531605416,Downregulated
Feature0269,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Phenol,341301.80240054964,386468.207076861,1.132335675811358,0.17930170202165746,0.5676710505890011,0.9897340531605416,Upregulated
Feature0268,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0268,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,1303549.4186364,1070771.9909623968,0.8214279993178134,-0.2837939708130236,0.7013511666427066,0.9897340531605416,Downregulated
Feature0267,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,479195.16049507365,304532.254183489,0.6355077832356776,-0.6540183004726238,0.07420598037876651,0.9897340531605416,Downregulated
Feature0266,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,6014571.100083251,6245101.13966096,1.038328591638815,0.054263074244217085,0.8052580599015218,0.9897340531605416,Upregulated
Feature0265,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,5066233.69003474,4326786.662988237,0.8540440350193494,-0.2276176369078572,0.700587077047492,0.9897340531605416,Downregulated
Feature0264,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1968641.4456926694,1637434.672304272,0.8317587115149545,-0.26576302347731917,0.7277159661912178,0.9897340531605416,Downregulated
Feature0263,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0263,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,113299.84526447963,191937.45770339065,1.6940663710117574,0.760490398432664,0.4199930582244009,0.9897340531605416,Upregulated
Feature0262,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,4818204.365344574,5166580.616013,1.0723041665011468,0.1007141942843313,0.8882453282482743,0.9897340531605416,Upregulated
Feature0261,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,156472.56142368176,235278.94399749534,1.5036434621941737,0.5884625216014377,0.5035939131078202,0.9897340531605416,Upregulated
Feature0260,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2653979.0238414602,2420961.9606362265,0.9122008647724891,-0.13257655700654886,0.8158171718985253,0.9897340531605416,Downregulated
Feature0259,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,87755.8046773801,187283.14376910476,2.134139666972694,1.093654595213576,0.5356341853242546,0.9897340531605416,Upregulated
Feature0258,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Phenol,2176220.5798323466,2777819.5028589,1.2764420705335393,0.352128064615059,0.5670650344093576,0.9897340531605416,Upregulated
Feature0257,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Phenol,5409207.5649380665,5051331.027130737,0.9338393778550764,-0.09875366989855995,0.6313797348115424,0.9897340531605416,Downregulated
Feature0256,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,288777.1706745307,141505.89576275766,0.4900175988019613,-1.0290945308669068,0.3058989658262737,0.9897340531605416,Downregulated
Feature0255,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1881887.5769353868,2029488.4551631066,1.0784323569785634,0.10893568849461148,0.8185257713894435,0.9897340531605416,Upregulated
Feature0254,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3710696.935693307,3168192.3927776567,0.8537998245835486,-0.22803022870901446,0.25999370447799885,0.9897340531605416,Downregulated
Feature0253,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1867190.67893936,2036679.0957091965,1.0907718845651655,0.12534941933614657,0.7651521222680557,0.9897340531605416,Upregulated
Feature0252,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Phenol,5257045.8125884,5312497.232253747,1.0105480191046774,0.015137877163678426,0.919160517431296,0.9897340531605416,Upregulated
Feature0251,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Phenol,2202370.0298784566,2247703.8935221964,1.0205841266584261,0.02939510849562763,0.9559457617193537,0.9977405996735952,Upregulated
Feature0250,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Phenol,2361454.2239150833,2343490.9662893433,0.9923931374812092,-0.011016336033539194,0.9786313008092496,0.9990212121416295,Downregulated
Feature0249,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,269612.75446185365,181986.40586925583,0.6749918275657998,-0.5670580599856239,0.3911878067894344,0.9897340531605416,Downregulated
Feature0248,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,4893070.848986637,4877761.258254264,0.9968711692095069,-0.004521025120552923,0.9849804215520885,0.9990212121416295,Downregulated
Feature0247,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,69111.83597244926,59672.82925396763,0.863424164824034,-0.21185862452957313,0.38402755865240407,0.9897340531605416,Downregulated
Feature0246,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,2807182.8075733334,1112726.8887381456,0.3963856168312891,-1.3350234807550945,0.13695529018676336,0.9897340531605416,Downregulated
Feature0245,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0245,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,1573595.5993091266,1415574.1605579932,0.899579384423475,-0.15267749549997,0.5529065785736846,0.9897340531605416,Downregulated
Feature0244,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Phenol,1423324.053218596,1266150.6101934074,0.8895729734421557,-0.16881513739391854,0.7622787044159284,0.9897340531605416,Downregulated
Feature0243,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,441198.17126031534,506922.21104347665,1.1489671627500533,0.20033756663970964,0.7196017895990688,0.9897340531605416,Upregulated
Feature0242,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Phenol,986921.9595555214,924562.5593183077,0.9368142540213631,-0.09416506767175484,0.8469928422735178,0.9897340531605416,Downregulated
Feature0241,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Phenol,233873.2218865147,257515.7481974107,1.101091207108646,0.1389339771615111,0.8998251574987175,0.9897340531605416,Upregulated
Feature0240,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,826045.735486224,612236.7009491993,0.741165621524366,-0.43213213042257465,0.1734801621285577,0.9897340531605416,Downregulated
Feature0239,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,1760075.5789240394,2164749.7591856853,1.2299186382149734,0.2985628813155973,0.798494068030366,0.9897340531605416,Upregulated
Feature0238,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0238,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1094952.0914864487,1210641.9020663768,1.1056574177806024,0.14490444323064514,0.3165356620652789,0.9897340531605416,Upregulated
Feature0237,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,889960.3576131014,964540.4232259879,1.0838015592210337,0.11610062778449898,0.6444718777113028,0.9897340531605416,Upregulated
Feature0236,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,4076584.10113168,2801191.3752230597,0.6871418093509797,-0.54132022796188894,0.07905423455820634,0.9897340531605416,Downregulated
Feature0235,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,1277709.5069391236,2013914.8511816815,1.5761914897277463,0.6564428168365387,0.6630895046757115,0.9897340531605416,Upregulated
Feature0234,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,538607.3977437296,1551266.0856110728,2.880142553016266,1.526140219806459,0.44435831209010923,0.9897340531605416,Upregulated
Feature0233,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,88399.68900091623,77406.3977109405,0.8756410637387899,-0.19158848269012868,0.4459168851473423,0.9897340531605416,Downregulated
Feature0232,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0232,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1939358.64634459,1804147.2903259667,0.9302803757966701,-0.1042625014516597,0.7760121755393117,0.9897340531605416,Downregulated
Feature0231,NA,C9 H15 N O5,217.09502,NA,NA,Feature0231,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,319699.702192894,318313.31790691835,0.9956634795826642,-0.006269881081469361,0.9896743948927131,0.9990212121416295,Downregulated
Feature0230,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Phenol,1572575.7949790333,1980642.2144126,1.2594891901150032,0.33283873982967466,0.25824534963247947,0.9897340531605416,Upregulated
Feature0229,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,2555668.734735267,2297450.197877833,0.8989624385399144,-0.15366725819578925,0.33345268400987504,0.9897340531605416,Downregulated
Feature0228,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,177883.665338103,144881.506799605,0.8144733611387484,-0.2960605813808992,0.32890260772039925,0.9897340531605416,Downregulated
Feature0227,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,1629153.9465030986,563625.828659037,0.3459622891187374,-1.531313306350346,0.21290285935010547,0.9897340531605416,Downregulated
Feature0226,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0226,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,4288815.7895054,4918880.974530693,1.146908894191036,0.19775079403979004,0.17343893960462278,0.9897340531605416,Upregulated
Feature0225,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,146319.59145147007,198667.30367113778,1.3577628375010184,0.44123150385242954,0.672609415210911,0.9897340531605416,Upregulated
Feature0224,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Phenol,4462475.001911427,3300394.9160936167,0.7395884379587443,-0.43520542372822435,0.16276533298194315,0.9897340531605416,Downregulated
Feature0223,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0223,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,92926.6074543551,97447.7515275484,1.0486528476293946,0.06853715847373083,0.6917483167704586,0.9897340531605416,Upregulated
Feature0222,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,412806.9333521393,758356.467556669,1.8370729905104657,0.8774089486896026,0.417737154607288,0.9897340531605416,Upregulated
Feature0221,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,207436.81723470666,350344.8966925763,1.6889234098505026,0.7561039055612986,0.6068112108246714,0.9897340531605416,Upregulated
Feature0220,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Phenol,151974.10583316983,172305.059072486,1.1337790614253362,0.18113953089657017,0.7674944328595354,0.9897340531605416,Upregulated
Feature0219,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,1700523.95368064,1597621.5706824334,0.9394878368073069,-0.09005361114663131,0.5140142724562305,0.9897340531605416,Downregulated
Feature0218,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,342741.9855831017,378989.5134426692,1.1057574775903225,0.14503499837131648,0.8407372432961562,0.9897340531605416,Upregulated
Feature0217,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0217,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,4132230.5003930735,3689502.16027072,0.8928597182368603,-0.1634945709428286,0.47527572908149235,0.9897340531605416,Downregulated
Feature0216,NA,C19 H41 N O,299.31886,NA,NA,Feature0216,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,2151644.4788210066,2045421.2260459852,0.9506315965204315,-0.07304174102138414,0.9203785282071734,0.9897340531605416,Downregulated
Feature0215,NA,C16 H35 N O,257.27187,NA,NA,Feature0215,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,4016782.1016340987,3006994.9259008584,0.7486079278927177,-0.41771776816839556,0.7071907520288465,0.9897340531605416,Downregulated
Feature0214,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0214,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,127959.74366763256,134866.99053863878,1.0539798429805187,0.07584727616856225,0.880570492050076,0.9897340531605416,Upregulated
Feature0213,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,2232376.4468029365,2269728.8430020865,1.0167321225112564,0.023939623707737594,0.9739865305433864,0.9990212121416295,Upregulated
Feature0212,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,105503.10608488474,124206.17254129933,1.1772750315177132,0.2354513979082394,0.332793062264683,0.9897340531605416,Upregulated
Feature0211,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,135159.32667407434,223274.72766069966,1.6519372591956485,0.7241588940417532,0.3422144669971494,0.9897340531605416,Upregulated
Feature0210,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0210,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,100113.91518426784,100623.73491126907,1.005092396257432,0.007328131747700591,0.9715788117026711,0.9990212121416295,Upregulated
Feature0209,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0209,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,689533.3242165013,647200.5128675806,0.9386065765610062,-0.09140752591399483,0.8955621553662403,0.9897340531605416,Downregulated
Feature0208,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Phenol,353203.55045307166,397391.739193272,1.1251068645360953,0.1700620375438571,0.8066010619319214,0.9897340531605416,Upregulated
Feature0207,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,854212.5735198354,555459.1140148347,0.650258648998845,-0.6209144115076252,0.42076544204366334,0.9897340531605416,Downregulated
Feature0206,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Phenol,121347.01880396494,104852.38263009467,0.8640705281724538,-0.21077902035518778,0.5636956105657901,0.9897340531605416,Downregulated
Feature0205,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0205,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,110627.07339107667,105933.31360689309,0.9575713282444821,-0.06254813936739881,0.7750967603460126,0.9897340531605416,Downregulated
Feature0204,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,1814501.089458727,426735.0785421116,0.23518039257248857,-2.0881603098729276,0.4722237167554114,0.9897340531605416,Downregulated
Feature0203,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1862289.8951603868,1864332.9640625108,1.001097073504739,0.001581874946802952,0.9973432167411437,0.9990212121416295,Upregulated
Feature0202,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,288037.58412831766,547963.20550659,1.9024017548434868,0.927821950990376,0.27558136815700485,0.9897340531605416,Upregulated
Feature0201,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0201,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,2328946.405090473,2008395.6568059532,0.8623623336355534,-0.2136339296261835,0.44926888828622946,0.9897340531605416,Downregulated
Feature0200,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0200,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Phenol,2439527.3982307566,1946942.62556988,0.7980818854430088,-0.3253913162820795,0.6938576635169303,0.9897340531605416,Downregulated
Feature0199,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,2980198.2402525763,3150375.79521517,1.0571027633880392,0.08011563123706829,0.9419117764908833,0.9897340531605416,Upregulated
Feature0198,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,209698.87035509024,498093.26353942667,2.375278716075048,1.2480968097412484,0.04329989542214476,0.9897340531605416,Upregulated
Feature0197,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0197,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,4954246.081334863,4143920.892916867,0.836438244060807,-0.25766906780504983,0.6006377910570588,0.9897340531605416,Downregulated
Feature0196,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,184554.871172703,128658.80182636797,0.6971303494122975,-0.5204996584946674,0.2218135786869416,0.9897340531605416,Downregulated
Feature0195,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,278599.8573050823,229250.42320579966,0.8228662621128255,-0.2812701219135684,0.6051581350315591,0.9897340531605416,Downregulated
Feature0194,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,2031367.0723145732,1398023.9405099072,0.6882182740694796,-0.5390618948214844,0.23374461858609105,0.9897340531605416,Downregulated
Feature0193,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Phenol,1022615.7045186233,1318633.0590448133,1.2894707691444407,0.36677906921992287,0.3616822558327346,0.9897340531605416,Upregulated
Feature0192,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Phenol,239208.30047965332,215727.03498996765,0.9018375807085216,-0.1490604647387797,0.6682601728934667,0.9897340531605416,Downregulated
Feature0191,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,3239508.5193082,2770178.8194564064,0.8551231777738867,-0.22579584428790753,0.2972483563212223,0.9897340531605416,Downregulated
Feature0190,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5355037.14947899,5023588.134967984,0.9381051885805771,-0.09217839545674719,0.5532723020718011,0.9897340531605416,Downregulated
Feature0189,NA,C14 H21 N O10,363.11672,NA,NA,Feature0189,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,69406.30283277243,58852.79435181347,0.8479459638357832,-0.2379557642852746,0.4445782799310208,0.9897340531605416,Downregulated
Feature0188,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0188,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,179018.66774305367,151720.7814697141,0.8475137446977298,-0.23869132929742623,0.6744373026768882,0.9897340531605416,Downregulated
Feature0187,NA,C19 H37 N O2,311.28246,NA,NA,Feature0187,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,2976415.979744726,2677235.610464021,0.8994830120128692,-0.15283206045476855,0.9218977140909929,0.9897340531605416,Downregulated
Feature0186,NA,C13 H25 N O9,339.15309,NA,NA,Feature0186,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,81663.5169810122,74169.76272633523,0.9082362047128173,-0.1388605473141001,0.633848383391376,0.9897340531605416,Downregulated
Feature0185,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0185,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,2627861.0210694834,1866966.2974734297,0.7104509266299076,-0.4931930940509003,0.5091773700839886,0.9897340531605416,Downregulated
Feature0184,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0184,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Phenol,3377758.289366577,3138819.095644916,0.9292610147760252,-0.1058442110539556,0.8980862134754097,0.9897340531605416,Downregulated
Feature0183,NA,C9 H21 N O7,255.13179,NA,NA,Feature0183,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,166852.47797317166,154188.25892279667,0.9240993049416306,-0.11388020098549613,0.5061819916050032,0.9897340531605416,Downregulated
Feature0182,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0182,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,2177143.0810249834,2243280.6085145967,1.0303781263004892,0.043173872194081274,0.796132121385521,0.9897340531605416,Upregulated
Feature0181,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Phenol,354017.7132497333,1034021.8677513413,2.920819577809982,1.5463732440835698,0.35647734571008133,0.9897340531605416,Upregulated
Feature0180,NA,C17 H31 N O9,393.19997,NA,NA,Feature0180,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,803363.1321210493,143586.64258238632,0.17873192936211435,-2.4841307088706843,0.3383678892860602,0.9897340531605416,Downregulated
Feature0179,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,704937.0227090303,606036.7244840406,0.8597033564148443,-0.2180891560683601,0.7637525471608814,0.9897340531605416,Downregulated
Feature0178,NA,C10 H23 N O6,253.15257,NA,NA,Feature0178,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,208606.4165918182,499251.6424000224,2.3932707850349204,1.258983638884643,0.5540374273915604,0.9897340531605416,Upregulated
Feature0177,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Phenol,907775.5199186109,1454294.6133771134,1.6020421144508303,0.6799120737832954,0.3442475861585339,0.9897340531605416,Upregulated
Feature0176,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,162099.14794199166,143366.14933596033,0.8844349347676086,-0.17717208282619287,0.5716925476988639,0.9897340531605416,Downregulated
Feature0175,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1333485.4993645267,2197026.334746157,1.647581721580888,0.7203500260196545,0.22754780746663728,0.9897340531605416,Upregulated
Feature0174,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0174,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,4129206.2148598568,4794873.733110546,1.161209560291549,0.2156283549005241,0.4255858693590729,0.9897340531605416,Upregulated
Feature0173,NA,C20 H33 N O11,463.2054,NA,NA,Feature0173,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,78427.4999812049,68590.1768951343,0.8745679374144514,-0.19335763622477667,0.5369515178371705,0.9897340531605416,Downregulated
Feature0172,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,134654.91866755165,134356.34055394825,0.9977826423530761,-0.0032025227638680016,0.9922542392058089,0.9990212121416295,Downregulated
Feature0171,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0171,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,71547.088549571,64522.952986036136,0.9018249979708367,-0.14908059383994715,0.4216947233878127,0.9897340531605416,Downregulated
Feature0170,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,2858935.4534904,3031191.43014773,1.060251789331944,0.0844069176979825,0.8069891712534548,0.9897340531605416,Upregulated
Feature0169,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1103446.225362564,1190008.7012848137,1.078447389580591,0.10895579852664443,0.8467576938356386,0.9897340531605416,Upregulated
Feature0168,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,53418.3206392855,46935.5547051549,0.8786415249197675,-0.18665341155028278,0.4923786703290943,0.9897340531605416,Downregulated
Feature0167,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0167,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,893270.40741559,1004255.0178243263,1.124245255957641,0.16895679619654358,0.8787689953753623,0.9897340531605416,Upregulated
Feature0166,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0166,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,1686699.3319397133,1610278.1190682664,0.9546918579830336,-0.06689293943075574,0.8522702436410732,0.9897340531605416,Downregulated
Feature0165,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,360811.14223298465,597525.3256314376,1.6560611790796658,0.7277559706177306,0.5985013971792127,0.9897340531605416,Upregulated
Feature0164,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0164,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Phenol,83979.34044139613,110321.07968327563,1.3136692798898766,0.39360211864579764,0.25819559555442195,0.9897340531605416,Upregulated
Feature0163,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0163,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1993611.55188236,930542.4472071003,0.46676216654567737,-1.0992404668946967,0.5018710118749691,0.9897340531605416,Downregulated
Feature0162,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0162,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1039420.0653410123,1084555.3674118577,1.0434235431620587,0.06132489092218562,0.8894091367987068,0.9897340531605416,Upregulated
Feature0161,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Phenol,578198.0473955794,869305.10090911,1.5034729100604642,0.5882988733169552,0.6821309054056979,0.9897340531605416,Upregulated
Feature0160,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0160,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Phenol,120210.39751280927,144406.98202949855,1.2012852882722642,0.26457881140912776,0.7397481150464028,0.9897340531605416,Upregulated
Feature0159,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Phenol,1404868.85409018,1746610.51775512,1.2432552068258773,0.3141224732449513,0.06789189571513952,0.9897340531605416,Upregulated
Feature0158,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,67578.9544065766,62411.10385539433,0.9235286991850921,-0.11477130040550271,0.6713262309778993,0.9897340531605416,Downregulated
Feature0157,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,903124.9999058163,1058513.7336060842,1.1720567293746413,0.2290424001413612,0.41277307344923875,0.9897340531605416,Upregulated
Feature0156,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,2149988.631257573,3051154.37135974,1.4191490722325617,0.5050261429394344,0.2790481503419214,0.9897340531605416,Upregulated
Feature0155,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0155,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,436282.94623267034,515946.32690016564,1.1825956786883225,0.24195691048652887,0.6236761792082355,0.9897340531605416,Upregulated
Feature0154,NA,C9 H9 O P S,196.01126,NA,NA,Feature0154,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,124699.00108029896,110551.59554156556,0.8865475632028257,-0.17373006121844026,0.5810510171797074,0.9897340531605416,Downregulated
Feature0153,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Phenol,139166.7073104232,181076.70430240282,1.301149591033262,0.3797868358723636,0.7085464887341916,0.9897340531605416,Upregulated
Feature0152,NA,C8 H11 N O7,233.05354,NA,NA,Feature0152,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,1176411.7044207894,1137929.9006457834,0.9672888295565262,-0.04798135642513078,0.9236443038389732,0.9897340531605416,Downregulated
Feature0151,NA,C23 H32,308.25044,NA,NA,Feature0151,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,364094.928104267,823814.369513549,2.262636213591063,1.1780046468950662,0.03800327923436805,0.9897340531605416,Upregulated
Feature0150,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0150,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3786767.27394052,3943623.3787717232,1.0414221665827323,0.058555019809531914,0.8965335747793035,0.9897340531605416,Upregulated
Feature0149,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0149,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,40531.3431425271,49532.98889470577,1.2220909808126685,0.28935169324279314,0.1876225668552332,0.9897340531605416,Upregulated
Feature0148,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0148,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Phenol,1728289.2806014833,1971293.9991174955,1.140604192390432,0.18979824058176162,0.8408018688037576,0.9897340531605416,Upregulated
Feature0147,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,2309583.66870215,2499282.153939556,1.08213535963562,0.11388097094014718,0.8926779797171324,0.9897340531605416,Upregulated
Feature0146,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0146,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,677060.7595947568,744730.2202177527,1.0999459201615795,0.13743259408389,0.7032430319413306,0.9897340531605416,Upregulated
Feature0145,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0145,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,110161.9202833763,492848.95902592136,4.473859549271977,2.16151996566181,0.451533800465573,0.9897340531605416,Upregulated
Feature0144,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Phenol,610941.2454146267,545422.2620949063,0.8927573088059316,-0.16366005500359354,0.6290274035787804,0.9897340531605416,Downregulated
Feature0143,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Phenol,3596334.129489727,4162736.53552021,1.1574943777848719,0.21100518600250262,0.36141787256656877,0.9897340531605416,Upregulated
Feature0142,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Phenol,3351092.0659034066,3452915.5587339066,1.030385167231462,0.04318373059580017,0.5363680464134175,0.9897340531605416,Upregulated
Feature0141,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Phenol,4175650.600352453,4106386.427778543,0.9834123639156821,-0.02413160138460997,0.7730054846921453,0.9897340531605416,Downregulated
Feature0140,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0140,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,466913.925640039,278275.12726532994,0.5959880654317053,-0.7466446536544322,0.31090492609087406,0.9897340531605416,Downregulated
Feature0139,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,385171.990961938,542656.8886168926,1.4088690282531915,0.49453750158930426,0.39629177692338957,0.9897340531605416,Upregulated
Feature0138,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,1896855.6014650166,1801628.3655058932,0.9497973193712924,-0.07430841042747795,0.750982854976554,0.9897340531605416,Downregulated
Feature0137,NA,C9 H19 N O8,269.11107,NA,NA,Feature0137,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,1516261.1864592184,370201.2317907693,0.24415399872845478,-2.034136688411188,0.22177378883700524,0.9897340531605416,Downregulated
Feature0136,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,67969.46753576084,72469.5607600067,1.066207569183593,0.09248832916706255,0.6829039044242209,0.9897340531605416,Upregulated
Feature0135,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Phenol,4371737.864185894,4235395.486304087,0.9688127737486847,-0.045710207866691485,0.8266811165791874,0.9897340531605416,Downregulated
Feature0134,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1102841.9739153148,1028602.3775298016,0.9326833779077637,-0.10054068867381219,0.8017403967729269,0.9897340531605416,Downregulated
Feature0133,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,468735.60500182497,429911.52144232066,0.9171727448369253,-0.12473461117759638,0.8477509712583788,0.9897340531605416,Downregulated
Feature0132,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,109949.92909087184,95760.60622864056,0.8709474123398112,-0.19934248312059047,0.49765934044999227,0.9897340531605416,Downregulated
Feature0131,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0131,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,393526.02164240467,288406.172937091,0.7328770070487597,-0.4483569923117302,0.4101599259804853,0.9897340531605416,Downregulated
Feature0130,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,238877.28837700668,167053.85906457301,0.6993291836138111,-0.5159563835269547,0.1489422108703737,0.9897340531605416,Downregulated
Feature0129,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,3618790.4522591066,3387861.1781026768,0.9361860607285876,-0.09513281057606995,0.564788704450379,0.9897340531605416,Downregulated
Feature0128,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,1904700.6443001232,1748125.8334013168,0.9177955804407577,-0.12375523528421709,0.6719585044735472,0.9897340531605416,Downregulated
Feature0127,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0127,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,384026.00364028104,312431.42284320865,0.813568403914295,-0.29766444371714235,0.6980666867420293,0.9897340531605416,Downregulated
Feature0126,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,3229096.9641933106,2491061.837638301,0.771442253131787,-0.3743699280310501,0.6887784101113991,0.9897340531605416,Downregulated
Feature0125,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Phenol,249790.28984010735,422249.47289322334,1.6904158811117456,0.7573782262742358,0.43834348415389845,0.9897340531605416,Upregulated
Feature0124,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,3030426.3581366865,2816143.4355849265,0.929289513346394,-0.10579996717086004,0.4924463033236782,0.9897340531605416,Downregulated
Feature0123,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0123,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,161494.913851433,235768.59033347934,1.4599134097212145,0.545882802618688,0.4051459537462024,0.9897340531605416,Upregulated
Feature0122,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,213081.384669788,279761.07123319735,1.3129306047393243,0.3927906642550008,0.4595615831993095,0.9897340531605416,Upregulated
Feature0121,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,580393.8955104966,644721.708225866,1.110834750697694,0.15164421539419945,0.7743391593212479,0.9897340531605416,Upregulated
Feature0120,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0120,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Phenol,459462.6239685038,405319.6554060963,0.88216023298095525,-0.18088736843397205,0.8880163324729748,0.9897340531605416,Downregulated
Feature0119,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0119,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Phenol,1991769.20903301,1839772.5447397667,0.92368761219728035,-0.11452307499327605,0.7459807458992693,0.9897340531605416,Downregulated
Feature0118,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Phenol,72286.51369902426,65361.3449169253,0.9041983292909527,-0.14528884293040747,0.6079681070589322,0.9897340531605416,Downregulated
Feature0117,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,640356.3810100884,797373.5405144066,1.2452027717075949,0.31638069323064527,0.18662051394789,0.9897340531605416,Upregulated
Feature0116,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Phenol,163748.81188679504,111874.12826015893,0.6832057403720353,-0.5496079981908493,0.46814268138878873,0.9897340531605416,Downregulated
Feature0115,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0115,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3516043.6922580334,3054814.7017599936,0.8688215986867232,-0.2028681262629249,0.6628307107393845,0.9897340531605416,Downregulated
Feature0114,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Phenol,219594.46201656034,140598.282188511,0.6402633331340933,-0.6432627034158116,0.06940290229712427,0.9897340531605416,Downregulated
Feature0113,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Phenol,113764.53901035526,102371.62261254917,0.8998552932494275,-0.15223507621907295,0.6316873956840803,0.9897340531605416,Downregulated
Feature0112,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,4147423.255634873,4093594.89009742,0.9870212509744889,-0.018846948052234615,0.9056795143926684,0.9897340531605416,Downregulated
Feature0111,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,4049638.9916023565,3785149.009569093,0.9346880098246461,-0.09744320773858169,0.6890297962075302,0.9897340531605416,Downregulated
Feature0110,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,2747842.986550097,2322704.7899238234,0.8452829369410104,-0.2424937672225243,0.6640521804181969,0.9897340531605416,Downregulated
Feature0109,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0109,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Phenol,155110.286751328,141960.8410911064,0.9152251863133828,-0.12780134033504717,0.788535637179664,0.9897340531605416,Downregulated
Feature0108,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,4436544.937103163,3903181.51748483,0.8797795520658939,-0.18478602452810855,0.5314472513770424,0.9897340531605416,Downregulated
Feature0107,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,157745.32925704034,556702.206572196,3.529120064563495,1.8193085130317197,0.46687816835948026,0.9897340531605416,Upregulated
Feature0106,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,1198222.312014181,1488900.6978234744,1.2425913646363926,0.3133519334469897,0.7289813063675946,0.9897340531605416,Upregulated
Feature0105,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,61104.18638425867,188721.05761596467,3.0885127318311203,1.62691227795108,0.09596126433342765,0.9897340531605416,Upregulated
Feature0104,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0104,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1299115.4129163234,1609402.5253168228,1.2388449165605313,0.3089955965885502,0.6445660060308682,0.9897340531605416,Upregulated
Feature0103,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0103,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,660310.933041641,790067.6857104059,1.1965085631265506,0.2588307219378425,0.6032805871938679,0.9897340531605416,Upregulated
Feature0102,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,2352000.321741776,1249948.7168120765,0.5314407082590983,-0.9120193526552384,0.3182979301036263,0.9897340531605416,Downregulated
Feature0101,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0101,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,425540.22743010835,404158.9339476823,0.9497549418264158,-0.07437278125327462,0.9147934039792591,0.9897340531605416,Downregulated
Feature0100,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0100,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Phenol,91188.492343987,111211.13401214436,1.2195742154901157,0.28637755400262777,0.550097167938708,0.9897340531605416,Upregulated
Feature0099,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1945243.1662082865,2099020.51467508,1.0790530207935596,0.1097657554251976,0.821087614411534,0.9897340531605416,Upregulated
Feature0098,NA,C9 H19 N O8,269.11113,NA,NA,Feature0098,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,376875.0047136382,469509.8793252067,1.2457973424954394,0.3170694000183164,0.6879560941585541,0.9897340531605416,Upregulated
Feature0097,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,467327.75147804996,315624.0052914567,0.675380403353344,-0.5662277757657077,0.23151163591294757,0.9897340531605416,Downregulated
Feature0096,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,1950210.4303669266,1932806.1353391232,0.991075683548401,-0.01293286178360648,0.9530073902578402,0.9965277650226437,Downregulated
Feature0095,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0095,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,159278.63001107232,183196.33073580833,1.1501626471992719,0.20183789048773443,0.6380813938735833,0.9897340531605416,Upregulated
Feature0094,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,1336537.0748539174,585935.291678714,0.4383980831528795,-1.1896866045995993,0.35406021342345684,0.9897340531605416,Downregulated
Feature0093,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,618876.1888075847,666625.517778963,1.0771548975949115,0.10722572799120078,0.840494430468992,0.9897340531605416,Upregulated
Feature0092,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,2649364.654610587,2417116.839893212,0.9123382980469665,-0.13235921521640567,0.8282421957037661,0.9897340531605416,Downregulated
Feature0091,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0091,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,601679.420898906,823893.9246960154,1.3693237562706102,0.45346359074808656,0.5712491284977371,0.9897340531605416,Upregulated
Feature0090,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,162736.21781201533,106298.19411320926,0.6531932199382904,-0.6144182788992224,0.2707241924440682,0.9897340531605416,Downregulated
Feature0089,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0089,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,867201.610052247,828060.6066000788,0.9548651628428019,-0.06663107130143638,0.8811501811169007,0.9897340531605416,Downregulated
Feature0088,NA,C14 H27 N O10,369.16362,NA,NA,Feature0088,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1825661.5169103867,1662472.3724461866,0.9106136910086328,-0.13508894455531728,0.28903709038742653,0.9897340531605416,Downregulated
Feature0087,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0087,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,249583.99064567467,211393.08946943632,0.8469817672301884,-0.23959718153969986,0.6676125986954717,0.9897340531605416,Downregulated
Feature0086,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Phenol,123004.5837524213,116267.57784565657,0.945229635341682,-0.0812632327251606,0.8932978101518625,0.9897340531605416,Downregulated
Feature0085,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,1778280.7305897034,1707865.4866284335,0.9604026278022373,-0.05828874388872305,0.8617614694277471,0.9897340531605416,Downregulated
Feature0084,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0084,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,4322708.98830849,3794961.9767922466,0.8779128983830218,-0.18785028417497115,0.2693370011866107,0.9897340531605416,Downregulated
Feature0083,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0083,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2016746.06000934,2222814.577407983,1.102178713267296,0.14035816931783626,0.667597918991305,0.9897340531605416,Upregulated
Feature0082,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Phenol,2097990.251011743,2265159.6641689297,1.0796807387815888,0.1106047710285935,0.8797554395891665,0.9897340531605416,Upregulated
Feature0081,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Phenol,284586.02225683467,183224.79347037166,0.6438292085372134,-0.6352500659811894,0.19015836337131395,0.9897340531605416,Downregulated
Feature0080,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,148818.68025339633,134686.509915111,0.9050376584833153,-0.14395027111496114,0.7671711678546714,0.9897340531605416,Downregulated
Feature0079,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0079,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,304085.84350340464,522970.980518719,1.7198136371411308,0.7822522397301843,0.4522539981765944,0.9897340531605416,Upregulated
Feature0078,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0078,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,606088.380457633,848893.7546708813,1.4006105083715938,0.48605581675050535,0.2761469581238,0.9897340531605416,Upregulated
Feature0077,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Phenol,4196079.998231627,3990251.932624247,0.9509475353915743,-0.07256234635495498,0.7472875014535414,0.9897340531605416,Downregulated
Feature0076,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0076,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,2943645.879598563,2025869.7545707144,0.6882178894585617,-0.5390627010721171,0.3015509558056308,0.9897340531605416,Downregulated
Feature0075,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,212704.16493327112,222503.25309586714,1.0460690939722321,0.06497814626839807,0.9604291382631545,0.9979064914529228,Upregulated
Feature0074,NA,C10 H15 N O5,229.09499,NA,NA,Feature0074,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,179558.49032032865,207503.32437644232,1.1556308142614735,0.20868057819958924,0.5279294095742905,0.9897340531605416,Upregulated
Feature0073,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0073,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,131011.49099736006,302569.551030801,2.3094886465867175,1.207573453936116,0.12728161751048855,0.9897340531605416,Upregulated
Feature0072,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0072,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,439549.92812079773,588962.7567426084,1.3399223138554326,0.4221493583961313,0.7042747038021294,0.9897340531605416,Upregulated
Feature0071,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,254180.66503266568,203685.773778147,0.8013425165599067,-0.31950907157781067,0.3249365878003584,0.9897340531605416,Downregulated
Feature0070,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,3537821.6043932335,3700541.19276113,1.0459942887357103,0.0648749743045842,0.869621061131751,0.9897340531605416,Upregulated
Feature0069,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0069,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,1741787.5139304532,1738166.2047776317,0.997920923692552,-0.0030025954736402883,0.9950194411003287,0.9990212121416295,Downregulated
Feature0068,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Phenol,3285904.92256315,3063417.6279895133,0.9322904040692429,-0.10114867729210014,0.4992475217559917,0.9897340531605416,Downregulated
Feature0067,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0067,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Phenol,369796.98744327936,671222.720621514,1.8151113811452244,0.8600580794031538,0.26790128770774874,0.9897340531605416,Upregulated
Feature0066,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0066,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,372799.4728006227,412942.737723881,1.107680583938828,0.14754191892936622,0.8259839404341663,0.9897340531605416,Upregulated
Feature0065,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,791401.0765918894,848923.0457954246,1.0726837136123815,0.10122475263848647,0.8840697158632403,0.9897340531605416,Upregulated
Feature0064,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,254739.1543490304,360898.61982695333,1.4167379205964887,0.5025729017805357,0.6656491460424327,0.9897340531605416,Upregulated
Feature0063,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0063,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,366854.6910166356,550986.0311197723,1.5019190012069028,0.5868070101170906,0.39650312768251395,0.9897340531605416,Upregulated
Feature0062,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0062,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,413358.0972828087,339321.3918319438,0.8208896694233356,-0.28473976334965995,0.7876352678551871,0.9897340531605416,Downregulated
Feature0061,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,181710.22737401834,206741.41320638076,1.1377533130308628,0.18618778730477284,0.8411228625125624,0.9897340531605416,Upregulated
Feature0060,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Phenol,81928.76652026213,168527.59319815188,2.057001470374544,1.0405428251225963,0.44802687723301066,0.9897340531605416,Upregulated
Feature0059,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0059,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,3048872.743335103,2796639.41605451,0.9172699720472164,-0.12458168275637432,0.8289418063044501,0.9897340531605416,Downregulated
Feature0058,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0058,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,475316.316679178,567653.3604771369,1.1942644099472042,0.25612228441558405,0.43318953702054896,0.9897340531605416,Upregulated
Feature0057,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0057,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Phenol,2930336.5734404633,2235257.957106495,0.7627990509233936,-0.39062504624058053,0.5766721154843671,0.9897340531605416,Downregulated
Feature0056,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Phenol,172680.74134565,143996.14944694535,0.8338865603936253,-0.2620769580866001,0.5313656867819927,0.9897340531605416,Downregulated
Feature0055,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Phenol,367524.44341187866,1064596.614781922,2.896668871596238,1.5343947744910442,0.5277997143952166,0.9897340531605416,Upregulated
Feature0054,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1709552.7511866868,1855857.4269875977,1.0855806734827886,0.11846694189857748,0.8008825809344506,0.9897340531605416,Upregulated
Feature0053,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0053,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1241971.0422098967,986380.8310261894,0.7942059818649847,-0.3324148677766199,0.6439848439807965,0.9897340531605416,Downregulated
Feature0052,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,590940.461982223,1507340.00004687,2.5507476590631812,1.3509201827408446,0.28835598472026425,0.9897340531605416,Upregulated
Feature0051,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,152817.79662760042,108706.41592392616,0.7113465729965426,-0.49137547270497456,0.6047718885654364,0.9897340531605416,Downregulated
Feature0050,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,47083.27539294307,701356.7030315369,14.89608989982582,3.8968617797738223,0.42208993258940913,0.9897340531605416,Upregulated
Feature0049,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0049,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,303357.63060391,320075.863714713,1.0551106398000312,0.07739428909513296,0.5523351176978416,0.9897340531605416,Upregulated
Feature0048,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0048,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1091425.0812140533,1645301.2715575178,1.5074798077091622,0.5921386777386549,0.6182904274662503,0.9897340531605416,Upregulated
Feature0047,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0047,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,1766132.9846941477,2872223.1739371684,1.626277975004566,0.7015738741933248,0.525725331948364,0.9897340531605416,Upregulated
Feature0046,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0046,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,104755.2853996725,97900.7727516433,0.9345664266783561,-0.09763088406453303,0.7625496834255214,0.9897340531605416,Downregulated
Feature0045,NA,C15 H33 N O,243.2562,NA,NA,Feature0045,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,1895845.2846623831,590831.8378183548,0.3116455981921392,-1.6820217592000755,0.29926575548657597,0.9897340531605416,Downregulated
Feature0044,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,157690.94151944498,173087.50845237935,1.0976376118030584,0.1344018230592775,0.7995187080784111,0.9897340531605416,Upregulated
Feature0043,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0043,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,1696706.7993108449,2480831.0014981977,1.4621447868929636,0.5480861792725181,0.6810386049393206,0.9897340531605416,Upregulated
Feature0042,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0042,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,572138.739297132,974920.258977912,1.703992741647933,0.7689191902522287,0.034067904588355756,0.9897340531605416,Upregulated
Feature0041,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Phenol,686454.7896298197,657028.913339043,0.9571335552824317,-0.0632078471874647,0.7188675319261033,0.9897340531605416,Downregulated
Feature0040,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0040,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Phenol,3090985.67660225,3058893.7769210036,0.9896175838263594,-0.0150569601008553,0.7666564547540065,0.9897340531605416,Downregulated
Feature0039,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,974563.809393726,901975.127701707,0.9255167481160865,-0.11166899760037327,0.36120629765289974,0.9897340531605416,Downregulated
Feature0038,NA,C12 H17 N O4,239.11576,NA,NA,Feature0038,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Phenol,2961807.0381313134,2793995.6313792635,0.9433415463628829,-0.08414788705047743,0.6336922676253267,0.9897340531605416,Downregulated
Feature0037,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1245371.7548509466,1144764.6748632533,0.9192152226065745,-0.1215254050439293,0.35553525276940084,0.9897340531605416,Downregulated
Feature0036,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0036,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Phenol,2803268.7034831136,2609849.4370426973,0.9310022381371827,-0.10314345884815568,0.8843257752823832,0.9897340531605416,Downregulated
Feature0035,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0035,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,558095.4322272603,463542.56070432503,0.8305793847020186,-0.26781003092294464,0.4351032335048207,0.9897340531605416,Downregulated
Feature0034,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0034,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2849922.73269686,2703614.8144844202,0.9486624965182864,-0.0760331806687192,0.859461036620707,0.9897340531605416,Downregulated
Feature0033,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,172907.85806138432,231566.01417381267,1.3392451723715415,0.4214200955287568,0.34949116906453703,0.9897340531605416,Upregulated
Feature0032,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0032,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Phenol,2206275.72222276,2126168.90609997,0.9636913848455512,-0.05335688706003094,0.45002055568189087,0.9897340531605416,Downregulated
Feature0031,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0031,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,584890.5097751654,547425.5806423386,0.9359453974604094,-0.09550372865868494,0.9040017646857228,0.9897340531605416,Downregulated
Feature0030,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,312781.44103396265,217930.92812954768,0.6967514677633452,-0.5212839584012361,0.34064563321256675,0.9897340531605416,Downregulated
Feature0029,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,115904.04591890286,102581.070150468,0.8850516764724776,-0.17616640103182116,0.5214170993155703,0.9897340531605416,Downregulated
Feature0028,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0028,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1463578.22879057,1222361.0149750938,0.8351866616553825,-0.2598294233498882,0.6750276824731607,0.9897340531605416,Downregulated
Feature0027,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0027,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Phenol,273938.83809228963,84738.16434143513,0.3093324222718903,-1.6927700393475722,0.10256038260963414,0.9897340531605416,Downregulated
Feature0026,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,489701.6470529157,517518.872713826,1.0568044355748398,0.07970842692863837,0.9433473545755429,0.9901176163084745,Upregulated
Feature0025,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0025,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,303513.38623245835,232378.96701895833,0.7656300432198442,-0.38528065279346607,0.32313558418797367,0.9897340531605416,Downregulated
Feature0024,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0024,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,3111590.6350137265,3007084.324767893,0.9664138627138616,-0.049286945351545305,0.7965730553504218,0.9897340531605416,Downregulated
Feature0023,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0023,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,2438606.6057053367,2463643.402276978,1.0102668452193417,0.01473640726182805,0.9846937307156802,0.9990212121416295,Upregulated
Feature0022,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0022,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,884673.9988960424,968629.248885978,1.0948996467565464,0.13079864538686453,0.5799259098901947,0.9897340531605416,Upregulated
Feature0021,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0021,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,130224.98436507443,147294.4785647598,1.131076953342782,0.1776970870901298,0.7364821579913845,0.9897340531605416,Upregulated
Feature0020,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0020,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1280482.7834953,1075499.3363465196,0.8399170611343618,-0.2516812210408916,0.5662797209851478,0.9897340531605416,Downregulated
Feature0019,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Phenol,124744.71785889503,108989.82721147686,0.8737029437571913,-0.19478524355382285,0.5305297824487873,0.9897340531605416,Downregulated
Feature0018,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,1451049.2337859767,1005606.0483932793,0.6930199368697656,-0.5290312383265879,0.20825555345709743,0.9897340531605416,Downregulated
Feature0017,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0017,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,261321.688481575,449753.0062250671,1.7210703360994768,0.7833060581383662,0.5863663985408141,0.9897340531605416,Upregulated
Feature0016,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Phenol,1334663.543834382,1751502.5115786002,1.3123176396552145,0.3921169590501375,0.4792424380663727,0.9897340531605416,Upregulated
Feature0015,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0015,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Phenol,214825.16012306465,206915.68320426065,0.9631817943751422,-0.05411997169851314,0.7355391009631267,0.9897340531605416,Downregulated
Feature0014,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0014,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,852045.722270269,904557.1152722007,1.061629783037952,0.08628074985845952,0.7599766374010687,0.9897340531605416,Upregulated
Feature0013,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2044680.3472333835,2009139.97193494,0.9826181264242441,-0.025297242058190245,0.9796089573144747,0.9990212121416295,Downregulated
Feature0012,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Phenol,1333560.12614189,1372902.2047735432,1.0295015409207482,0.04194598934564855,0.8435463019746203,0.9897340531605416,Upregulated
Feature0011,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Phenol,80013.17316562496,86551.7589559456,1.0817188661770225,0.11332559798800113,0.5985972455461976,0.9897340531605416,Upregulated
Feature0010,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0010,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,544594.5627195727,489301.6268239303,0.8984695410480726,-0.15445849902497966,0.8317985538393022,0.9897340531605416,Downregulated
Feature0009,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0009,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,1025803.048159556,996382.6212826234,0.9713196144915759,-0.04198199968599964,0.9322835235607324,0.9897340531605416,Downregulated
Feature0008,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,195882.65396950766,84898.54342779556,0.43341532140467837,-1.2061779407085453,0.13050384532369075,0.9897340531605416,Downregulated
Feature0007,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0007,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,902934.8689776587,1057376.2355647,1.1710437506549132,0.2277949764999236,0.5152567850757638,0.9897340531605416,Upregulated
Feature0006,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,281114.9137817087,248918.20014291268,0.8854677853776289,-0.17548827432616265,0.5116986731530186,0.9897340531605416,Downregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,366566.055609247,381506.5535808977,1.0407579963911797,0.05763464308978778,0.8591729978293591,0.9897340531605416,Upregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Phenol,1836263.9194603635,1593540.8449862127,0.8678168906431045,-0.20453742874895428,0.7767601783566022,0.9897340531605416,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,237269.5491988153,486374.41358573333,2.049881306843069,1.0355403765666493,0.49408873092422106,0.9897340531605416,Upregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Phenol,298225.9010841767,377855.26024261385,1.267010205582248,0.34142814522347426,0.822778258947727,0.9897340531605416,Upregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,80804.19015878683,87547.24570363789,1.0834493301844916,0.11563168430293475,0.7871691158479377,0.9897340531605416,Upregulated
